{"study_id": 27174, "supplement_id": 1396, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of Omega-3 PUFAs, particularly EPA and DHA, in modulating migraine pathophysiology and their role as a prophylactic treatment.", "results_summary": "Omega-3 PUFAs demonstrated anti-inflammatory, anti-nociceptive, and neuromodulatory properties, potentially alleviating migraine symptoms, though not all trials showed consistent benefits. Further research is needed to confirm clinical efficacy and understand molecular mechanisms.", "population_specificity": "Individuals with migraine (general population, not further specified).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:29.146150+00:00"}
{"study_id": 27172, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to characterize the fatty acid profile of Tetraselmis chuii fractions obtained by supercritical carbon dioxide extraction and evaluate the effect of biomass pretreatment on lipid yield and nutritional quality.", "results_summary": "The study found that T. chuii is a significant source of omega-3 fatty acids, particularly \u03b1-linolenic acid, and that pretreatment improved lipid yield. Supercritical carbon dioxide extraction enhanced the nutritional quality indices of the extracts compared to conventional solvent extraction.", "population_specificity": "Not specified (in vitro or lab-based study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:29.267725+00:00"}
{"study_id": 27176, "supplement_id": 1396, "safety_score": "65", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review the role of omega-3 PUFAs in auditory health across all life stages, examining both deficiency and excessive intake effects.", "results_summary": "The study found that both deficiency and excessive intake of omega-3 PUFAs, particularly DHA, can impair auditory function, with excessive intake potentially causing toxicity and hearing impairments. Some evidence suggests omega-3 may prevent age-related hearing loss, but human studies are limited.", "population_specificity": "Animal and human studies across fetal development to old age (presbycusis).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:29.634719+00:00"}
{"study_id": 27169, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effect of omega-3 fatty acids on intestinal neomucosa formation and inflammatory response in a rat model of short bowel syndrome.", "results_summary": "Omega-3 fatty acids showed a 60% rate of intestinal neomucosa formation, similar to the control group (57.1%), but increased inflammatory response, granulation tissue formation, and fibroblastic activity compared to the sham group.", "population_specificity": "Adult male Sprague-Dawley rats", "effective_dosage": "100 mg/kg/day", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:29.984429+00:00"}
{"study_id": 27180, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of omega-3 fatty acid supplementation on hematocrit, hemoglobin levels, and platelet counts in hemodialysis patients.", "results_summary": "Omega-3 supplementation significantly reduced platelet counts compared to the control group, suggesting a potential decrease in blood clot risk. No significant changes were observed in hematocrit or hemoglobin levels.", "population_specificity": "End-stage renal disease patients undergoing hemodialysis in Rasht, Iran.", "effective_dosage": "3 g/day (three capsules daily)", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:36.593475+00:00"}
{"study_id": 27179, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of omega-3 fatty acid supplementation in improving depression in patients with dementia, focusing on different types, dosages, and durations of intervention.", "results_summary": "Omega-3 supplementation showed a non-significant trend toward affecting depressive symptoms overall, but DHA supplementation significantly reduced symptoms. Low doses of EPA were effective, particularly in patients with mild cognitive impairment (MCI).", "population_specificity": "Patients with dementia, including subgroups with mild cognitive impairment (MCI) to severe dementia.", "effective_dosage": "High, medium, and low doses of EPA and DHA (specific amounts not detailed in abstract).", "study_duration": "3 months, 6 months, 12 months, and \u226524 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:37.957395+00:00"}
{"study_id": 27181, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effect of omega-3 fatty acids combined with rosuvastatin on lipoprotein(a) [Lp(a)] levels in patients with mixed hyperlipidemia.", "results_summary": "Omega-3 fatty acids (2 g/day) combined with rosuvastatin did not significantly increase Lp(a) levels, unlike rosuvastatin alone or combined with fenofibrate. The R\u03a9 group showed no significant change in Lp(a) levels, while the other groups exhibited increases.", "population_specificity": "Patients with mixed hyperlipidemia (LDL-C > 160 mg/dl and triglycerides > 200 mg/dl).", "effective_dosage": "2 g/day of omega-3 fatty acids.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:38.778245+00:00"}
{"study_id": 27178, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to characterize the changes in omega-3 fatty acid intake and the n-6:n-3 ratio in women with stage IV breast cancer following a whole-food, plant-based (WFPB) diet intervention.", "results_summary": "The WFPB diet significantly increased total n-3 PUFA intake by 1.1 g/day (p = 0.0005) and decreased the n-6:n-3 ratio from 9.3 to 3.7 (p < 0.0001). Linoleic acid (n-6 PUFA) consumption also decreased by 3.8 g/day (p = 0.0095).", "population_specificity": "Women with stage IV breast cancer on stable therapy.", "effective_dosage": "Not specified (dietary intake measured via food records).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:38.809628+00:00"}
{"study_id": 27183, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether prescription omega-3 ethyl esters (P-OM3) induce measurable changes in HDL-apolipoprotein A-I exchange (HAE), a functional property linked to reverse cholesterol transport, in subjects with metabolic syndrome.", "results_summary": "P-OM3 significantly increased HAE by 11.1% compared to placebo and improved apoA-I specific exchange activity by 28%, indicating enhanced HDL functionality without raising traditional HDL-C or apoA-I levels. The combination with niacin showed no additional significant effect.", "population_specificity": "Fifty-six subjects with metabolic syndrome (MetS).", "effective_dosage": "4g/day of prescription omega-3 ethyl esters (P-OM3).", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:39.229422+00:00"}
{"study_id": 27185, "supplement_id": 1396, "safety_score": "80", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the potential of icosapent ethyl (IPE), an omega-3 fatty acid, to reduce residual cardiovascular risk in statin-treated patients with elevated triglyceride levels.", "results_summary": "IPE significantly reduced CV events by 25%, including coronary revascularization, myocardial infarction, stroke, and CV death, with benefits observed across all patient subgroups. Adverse events like atrial fibrillation were noted but were outweighed by the net clinical benefit.", "population_specificity": "Statin-treated patients with hyperlipidemia and elevated triglyceride levels, including those with type-2 diabetes, prior revascularization, or renal dysfunction.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Combination with other omega-3 fatty acids (e.g., DHA) eliminated the beneficial effects of EPA alone.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:39.791455+00:00"}
{"study_id": 27182, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether add-on EPA (Omega-3 fatty acid) had greater antidepressant efficacy in MDD patients with high baseline inflammation (hs-CRP \u22651 mg/L) compared to those with low inflammation.", "results_summary": "EPA showed greater antidepressant efficacy in MDD patients with hs-CRP \u22651 mg/L, improving symptoms like fatigue and sleep difficulties, but not in those with hs-CRP \u22653 mg/L. The study supports the relevance of inflammation-based MDD subgroups for predicting treatment response to anti-inflammatory interventions.", "population_specificity": "Patients with major depressive disorder (MDD), specifically those with high baseline inflammation (hs-CRP \u22651 mg/L).", "effective_dosage": "2.2 g EPA, 400 mg docosahexaenoic acid, and 800 mg of other fatty acids daily.", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:39.826368+00:00"}
{"study_id": 27184, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of increasing omega-3 fatty acids (via O3 trial feed) on nursery pig growth performance, mortality, and immune response to LPS challenge or natural PRRSV infection.", "results_summary": "Omega-3 fatty acids did not improve growth performance or immune response in healthy pigs subjected to an LPS challenge. However, in pigs exposed to a natural PRRSV outbreak, higher omega-3 levels improved growth performance and reduced mortality in one experiment but increased removals and mortality in another.", "population_specificity": "Nursery pigs (varying breeds and initial weights).", "effective_dosage": "0%, 0.75%, 1%, 1.5%, 2%, 3%, and 4% O3 trial feed (dietary inclusion).", "study_duration": "Not explicitly stated (follow-up measurements taken at specific time points post-intervention).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:40.060727+00:00"}
{"study_id": 27187, "supplement_id": 1396, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the fatty acid profile, therapeutic potential, and safety of Omega-3 fatty acids extracted from Garfish skin, focusing on antioxidant, antimicrobial, antibiofilm, and toxicity properties.", "results_summary": "The study found that Omega-3 fatty acids from Garfish skin exhibited high antioxidant activity, effective antibacterial effects against multiple pathogens, and significant antibiofilm properties, while being non-toxic in brine shrimp larvae tests.", "population_specificity": "Not specified (in vitro and brine shrimp larvae assays).", "effective_dosage": "4000 \u00b5g/mL for antibiofilm effects (specific dosage frequency not mentioned).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:46.645864+00:00"}
{"study_id": 27192, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore whether omega-3 fatty acids could alleviate acne vulgaris by modulating gut microbiota.", "results_summary": "Omega-3 fatty acids increased gut microbiota diversity, positively regulated flora structure, raised butyric acid-producing bacteria abundance, improved GAGS scores in patients, and reduced inflammation and comedones in rats.", "population_specificity": "Untreated acne patients and Sprague Dawley rats with an acne model.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:47.154198+00:00"}
{"study_id": 27189, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy of different Omega-3 Fatty Acid formulations (EPA-only vs. EPA/DHA combinations) in reducing cardiovascular disease events and their underlying mechanisms of action.", "results_summary": "EPA-only formulations significantly reduced cardiovascular disease events in high-risk patients, while low-dose EPA/DHA mixtures failed to prevent such events. The benefits of EPA appear linked to its unique chemical and biological properties, distinct from DHA.", "population_specificity": "High-risk cardiovascular disease patients.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:47.621084+00:00"}
{"study_id": 27190, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Omega-3 Fatty Acids could mitigate HAART-induced male reproductive impairment, oxidative stress, and inflammation in rats.", "results_summary": "Omega-3 supplementation significantly improved sperm count, viability, motility, and serum testosterone levels while reducing oxidative stress markers (malondialdehyde) and inflammatory cytokines (tumor necrosis factor-alpha, interleukin-6) compared to HAART-only treatment.", "population_specificity": "Male adult Wistar rats (non-HIV model).", "effective_dosage": "Not specified.", "study_duration": "6 weeks.", "interactions": "Co-administered with HAART (highly active anti-retroviral therapy).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:47.792429+00:00"}
{"study_id": 27186, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate how omega-3 fatty acids protect pancreatic \u03b2 cells from immune attack and reduce the incidence of type 1 diabetes by examining the role of ARH3 and its regulation of CXCL9 expression.", "results_summary": "Omega-3 fatty acids upregulated ARH3, which reduced pro-inflammatory cytokine-induced \u03b2-cell apoptosis and regulated pathways related to nucleus, mitochondria, and endoplasmic reticulum. ARH3 also modulated cytokine-signaling proteins, including CXCL9, suggesting a protective role against immune attack and T1D development.", "population_specificity": "MIN6 insulin-producing cells (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:48.911530+00:00"}
{"study_id": 27193, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate whether omega-3 fatty acids supplementation improves cardiovascular outcomes in patients with established coronary artery disease (CAD).", "results_summary": "Omega-3 fatty acids reduced incidences of all-cause death, cardiovascular death, myocardial infarction, revascularization, sudden cardiac death, and hospitalization for heart failure or unstable angina pectoris in CAD patients, but did not significantly affect major adverse cardiovascular events (MACEs) or stroke. The benefits were more pronounced in subgroups using EPA and with baseline triglyceride levels \u22651.7 mmol/L.", "population_specificity": "Patients with established coronary artery disease (CAD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:48.917864+00:00"}
{"study_id": 27191, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 85, "study_goal": "The researchers aimed to determine whether omega-3 fatty acids reduced the hazard of substantive cognitive impairment in people with dysglycaemia and additional cardiovascular risk factors.", "results_summary": "The study found that omega-3 fatty acids had no significant effect on reducing the hazard of substantive cognitive impairment compared to placebo (hazard ratio 0.93, 95% CI 0.86, 1.01; p = .074). The effect was neutral, similar to the primary analysis of cognitive test scores as continuous variables.", "population_specificity": "People with dysglycaemia and additional cardiovascular risk factors from 40 countries.", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 6.2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:49.017024+00:00"}
{"study_id": 27188, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effects of high-dose EPA/DHA on peripheral artery disease (PAD) severity indicators (ABI and RLP-C levels) in hemodialysis patients with dyslipidemia.", "results_summary": "High-dose EPA/DHA significantly reduced RLP-C levels and improved ABI compared to conventional therapy alone, with a negative correlation between RLP-C reduction and ABI improvement. The treatment enhanced conventional therapy's effectiveness for PAD management in this population.", "population_specificity": "Hemodialysis patients with dyslipidemia (mean age: 73.6 \u00b1 12.7 years).", "effective_dosage": "High-dose EPA/DHA (EPA: 1860 mg; DHA: 1500 mg) for the intervention group; low-dose (EPA: 930 mg; DHA: 750 mg) for the continuation phase.", "study_duration": "3 months (with an optional 3-month continuation for the control group).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:50.920438+00:00"}
{"study_id": 27196, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the proteomic changes induced by Omega-3 Fatty Acids (DHA and EPA) in intestinal epithelial cells, particularly during LPS-induced metabolic dysregulation.", "results_summary": "The study found that Omega-3 Fatty Acids modulated central carbon metabolism pathways, mitigated LPS-induced metabolic dysregulation in enterocytes, and supported enterocyte development and lipid homeostasis.", "population_specificity": "Porcine enterocyte cell line (IPEC-J2)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:55.395593+00:00"}
{"study_id": 27194, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy and acceptability of high-dosage EPA/DHA supplementation against other FDA-approved or guideline-recommended pharmacologic interventions for migraine prophylaxis.", "results_summary": "High-dosage EPA/DHA supplementation showed the highest reduction in migraine frequency and severity, along with the most favorable acceptability rates among all studied treatments. The study concluded that EPA/DHA could be a first-choice treatment for migraine prophylaxis due to its superior efficacy and acceptability.", "population_specificity": "Participants with episodic or chronic migraine (N = 6616; mean age = 35.0 y; 78.9% women).", "effective_dosage": "High dosage (specific amount not stated in abstract).", "study_duration": "Not specified in abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:56.250092+00:00"}
{"study_id": 27198, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether omega-3 fatty acids, when used as an adjunct to nonsurgical periodontal therapy, provide additional benefits in treating periodontitis.", "results_summary": "The systematic review and meta-analysis found that omega-3 fatty acids as an adjunct to nonsurgical periodontal therapy may offer additional benefits in improving periodontal outcomes, though the extent of these benefits varied across studies.", "population_specificity": "Patients with periodontitis undergoing nonsurgical periodontal therapy.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:56.673174+00:00"}
{"study_id": 27197, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effects of combining omega-3 fatty acids with statin therapy on cardiovascular outcomes, lipid biomarkers, inflammatory markers, and plaque markers.", "results_summary": "The study found that omega-3 + statin therapy significantly reduced the incidence of MI, MACE, unstable angina, hospitalization due to unstable angina, total cholesterol, triglycerides, hsCRP, and lipid volume index compared to placebo + statin, but showed no significant difference in stroke, coronary revascularization, or cardiovascular mortality.", "population_specificity": "40,991 patients with various cardiovascular disturbances.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:56.736039+00:00"}
{"study_id": 27195, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to clarify the cardiovascular benefits of omega-3 fatty acids (O3FA) and explore reasons for conflicting trial results, including dosing and measurement issues.", "results_summary": "Epidemiological studies show an inverse association between O3FA intake and cardiovascular events, but recent trials report discordant findings, possibly due to insufficient dosing and lack of blood-level titration. The efficacy of supplementation depends on background tissue levels.", "population_specificity": "Individuals at risk for cardiovascular events (general population inferred from epidemiological data).", "effective_dosage": "Less than 1 g/day noted as insufficient; optimal dosage not specified.", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:56.806490+00:00"}
{"study_id": 27200, "supplement_id": 1396, "safety_score": "85", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine if a high-protein, increased-fibre diet supplemented with omega-3 fatty acids could improve quality of life and reduce adverse effects in dogs with cancer undergoing chemotherapy.", "results_summary": "The test diet significantly improved 10 out of 12 QOL parameters in dogs compared to the control diet, though only one parameter showed statistically significant between-group differences. No significant adverse events or differences in laboratory parameters were observed between the groups.", "population_specificity": "Client-owned dogs with newly diagnosed grade 2 or higher mast cell tumours or multicentric lymphoma.", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:57.736776+00:00"}
{"study_id": 27199, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the effect of omega-3 fatty acids coadministered with glimepiride on blood glucose, lipid profile, serum irisin, and sirtuin-1 levels in type 2 diabetes mellitus (T2DM) patients.", "results_summary": "Omega-3 supplementation significantly improved glycemic control (reduced FBG, HbA1C%, HOMA-IR), lipid profile (lowered TC, TGs, LDL, AIP; increased HDL), and increased serum irisin levels compared to the control group. The results suggest omega-3 fatty acids may enhance metabolic outcomes in T2DM patients using glimepiride.", "population_specificity": "70 type 2 diabetic patients.", "effective_dosage": "1000 mg fish oil capsules (13% EPA, 9% DHA) daily.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:54:59.596737+00:00"}
{"study_id": 27201, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine whether omega-3 fatty acids, alone or combined with minocycline, could prevent the transition to psychosis in individuals with an at-risk mental state (ARMS).", "results_summary": "Omega-3 supplementation increased the risk of transition to psychosis (17.3% vs. 10.4% without omega-3) but improved symptom severity in non-psychotic participants, reducing CAARMS and depression scores. Minocycline showed no significant effect on transition or symptom severity.", "population_specificity": "Help-seeking individuals aged 16-35 years with an at-risk mental state (ARMS) in Pakistan.", "effective_dosage": "Not specified in the abstract.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:01.362096+00:00"}
{"study_id": 27204, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether higher plasma levels of omega-3 fatty acids are associated with disease progression and transplant-free survival in patients with pulmonary fibrosis.", "results_summary": "Higher plasma omega-3 fatty acid levels were associated with improved diffusing capacity for carbon monoxide and longer transplant-free survival, particularly in patients with shorter telomere length, but no significant association was found with changes in FVC.", "population_specificity": "Patients with clinically diagnosed pulmonary fibrosis, predominantly idiopathic pulmonary fibrosis (88%) and male (74%).", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:04.985286+00:00"}
{"study_id": 27205, "supplement_id": 1396, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of omega-3 fatty acid supplementation on glycemic control, lipid profile, albuminuria, kidney injury markers, and atherosclerosis in pediatric patients with type 1 diabetes mellitus and diabetic nephropathy.", "results_summary": "Omega-3 supplementation significantly improved glycemic control, lipid profile, reduced albuminuria, kidney injury markers, and delayed subclinical atherosclerosis compared to placebo. The intervention was safe and well-tolerated.", "population_specificity": "Pediatric patients (mean age 15.2 years) with type 1 diabetes mellitus and diabetic nephropathy.", "effective_dosage": "1 g daily", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:05.543039+00:00"}
{"study_id": 27203, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to investigate the effects of linseed (omega-3 PUFA) supplementation on serum lipid profiles and immune-related gene expression (IL-2 and TLR-2) in lactating goats.", "results_summary": "Linseed supplementation (10% and 20%) significantly reduced triglycerides, cholesterol, and LDL while increasing HDL. Gene expression analysis showed higher relative expression in the 20% group, though no significant effect on TLR-2 and IL-2 gene expression was observed.", "population_specificity": "15 lactating Beetal goats", "effective_dosage": "10% and 20% of concentrate per day per animal", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:05.722240+00:00"}
{"study_id": 27202, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the benefits of Omega-3 fatty acids combined with antioxidant vitamins in improving metabolic parameters, insulin sensitivity, and mineral levels in obese children.", "results_summary": "The study found that Omega-3 fatty acids with antioxidant vitamins improved calcemia, magnesemia, insulin sensitivity, and adipocytokine levels in obese children after three months of treatment. Obese children initially showed lower serum mineral and vitamin D levels, insulin resistance, and adipocytokine imbalance.", "population_specificity": "60 obese children compared with 35 normal-weight children.", "effective_dosage": "Daily pill containing 130mg docosahexaenoic acid, 25mg eicosapentaenoic acid, vitamin A 200\u00b5g, vitamin D 1.25\u00b5g, vitamin E 2.5mg, and vitamin C 30mg.", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:05.898445+00:00"}
{"study_id": 27206, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effects of n-3 PUFAs supplementation on flow-mediated dilatation (FMD) of the brachial artery to assess endothelial function.", "results_summary": "The meta-analysis found a significant improvement in FMD (WMD = 0.8%, 95% CI = 0.3-1.3, p = .001) with n-3 PUFA supplementation, indicating enhanced endothelial function. Heterogeneity was high (I\u00b2 = 82.5%, p < .001), suggesting variability across studies.", "population_specificity": "2385 subjects (specific demographics not detailed).", "effective_dosage": "Not specified in the abstract.", "study_duration": "4 to 48 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:06.321621+00:00"}
{"study_id": 27208, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to review recent evidence on the effects of omega-3 fatty acids on inflammatory bowel diseases (IBD) and establish the contribution of the gut microbiome.", "results_summary": "Omega-3 fatty acids mediate anti-inflammatory effects in IBD through mechanisms like suppressing NLRP3 inflammasome, TLR4, and NOD2 signaling, reducing pro-inflammatory cytokines. They also promote a balanced gut microbiome by increasing SCFA-producing bacteria and enhancing the gut barrier, suggesting potential benefits for IBD patients.", "population_specificity": "Patients with inflammatory bowel diseases (IBD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:07.846027+00:00"}
{"study_id": 27207, "supplement_id": 1396, "safety_score": "80", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether omega-3 fatty acids could reduce paclitaxel-associated acute pain syndrome (P-APS) and subsequent chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer patients.", "results_summary": "The study found no significant difference in P-APS incidence between the omega-3 and placebo groups, with higher analgesic and opiate use in the intervention arm and no reduction in CIPN. The results did not support further investigation of omega-3 fatty acids for preventing P-APS or CIPN.", "population_specificity": "Breast cancer patients receiving weekly paclitaxel.", "effective_dosage": "4 g of omega-3 acid ethyl esters (Lovaza) daily.", "study_duration": "From 1 week prior to paclitaxel initiation until paclitaxel was stopped.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:08.412940+00:00"}
{"study_id": 27209, "supplement_id": 1396, "safety_score": "85", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to assess the efficacy and clinical use of omega-3 fatty acids in treating depression in children and adolescents.", "results_summary": "The study found significant heterogeneity in the results, making it difficult to determine the clinical use of omega-3 fatty acids as monotherapy for depression. However, omega-3 fatty acids were well tolerated with minimal side effects.", "population_specificity": "Children and adolescents with depression.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:09.059625+00:00"}
{"study_id": 27210, "supplement_id": 1396, "safety_score": "90", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy of omega-3 fatty acid supplementation in reducing mortality and inflammation in hospitalized COVID-19 patients.", "results_summary": "Omega-3 fatty acids were associated with reduced mortality in hospitalized COVID-19 patients, though no significant changes were observed in inflammatory markers like CRP and IL-6. The neutrophil/lymphocyte ratio improved significantly by day 7 of intervention.", "population_specificity": "Hospitalized patients with COVID-19.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:12.395260+00:00"}
{"study_id": 27213, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential of Omega-3 fatty acids to reduce postoperative atrial fibrillation (POAF) following CABG surgery by modulating inflammatory responses.", "results_summary": "The study suggests Omega-3 fatty acids may reduce POAF by mitigating inflammation and altering eicosanoid metabolism, though no specific efficacy data or statistical outcomes are provided.", "population_specificity": "Patients undergoing isolated CABG surgery.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:13.429463+00:00"}
{"study_id": 27214, "supplement_id": 1396, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Omega-3 fatty acids could prevent the adverse effects of adolescent nicotine withdrawal on spatial and avoidance memory in male rats.", "results_summary": "Omega-3 fatty acids significantly prevented nicotine withdrawal-induced adverse effects by restoring biochemical disturbances, including oxidative stress, inflammation, and neurotrophic capacity in hippocampal tissues. The study suggests Omega-3 fatty acids as a safe and effective therapeutic strategy for memory dysfunction associated with nicotine abstinence.", "population_specificity": "Male Wistar rats (adolescent)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:14.918637+00:00"}
{"study_id": 27211, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of standard periodontitis treatment alone versus adjunctive use of omega-3 PUFAs combined with low-dose aspirin.", "results_summary": "Adjunctive use of omega-3 PUFAs with low-dose aspirin significantly improved clinical outcomes such as probing depth, clinical attachment loss, and gingival index in periodontitis patients, though further studies are needed due to limited sample size and heterogeneity.", "population_specificity": "Adults over 18 years old with periodontitis.", "effective_dosage": "Not specified", "study_duration": "Follow-up periods ranged from 6 weeks to 6 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:15.263105+00:00"}
{"study_id": 27212, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether \u03c93-PUFAs (DHA/EPA) could attenuate kidney injury in a UUO model and investigate their mechanism of action.", "results_summary": "\u03c93-PUFAs reduced oxidative stress, inflammation, and fibrosis in UUO mice by enhancing autophagy flux and AMPK phosphorylation, demonstrating a renoprotective effect.", "population_specificity": "C57BL/6 mice and immortalized human proximal tubular cells (HK2).", "effective_dosage": "Various concentrations (not specified in abstract).", "study_duration": "72 hours for HK2 cells; 7 days for mice.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:15.264685+00:00"}
{"study_id": 201163, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential role of erythrocyte membrane fluidity as a biomarker for cardiovascular risk and dissect the biological mechanisms linking omega-3 fatty acids to cardiovascular health.", "results_summary": "The study found that omega-3 fatty acids reduce triglycerides and may influence erythrocyte membrane fluidity, but their impact on major cardiovascular events remains unclear, with conflicting results from trials like REDUCE-IT and STRENGTH.", "population_specificity": "Patients at high cardiovascular risk.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:16.543993+00:00"}
{"study_id": 201161, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the definition, classification, structural and functional characteristics, nutritional sources, and dosing recommendations of Omega-3 fatty acids (n-3 PUFAs).", "results_summary": "The study highlights the positive effects of n-3 PUFAs in nutrition and supplementation, discussing their importance, sources, and recommended daily doses, but does not provide specific efficacy outcomes.", "population_specificity": "General nutrition and supplementation context (no specific population mentioned).", "effective_dosage": "Not specified (discusses maximum and recommended daily doses but no specific intervention dosage).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:16.988321+00:00"}
{"study_id": 201164, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to examine the effects of omega-3 fatty acids, particularly DHA and EPA, on sleep quality and circadian processes in various populations.", "results_summary": "DHA-rich interventions improved sleep quality in healthy adults, while EPA-rich interventions showed no benefit in menopausal women, men with prostate cancer, and individuals with episodic migraines. Omega-3 fatty acids, especially DHA, may play a role in both preventing and improving sleep disturbances.", "population_specificity": "Healthy adults, menopausal women, men with prostate cancer, and individuals with episodic migraines.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:18.305441+00:00"}
{"study_id": 201165, "supplement_id": 1396, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effects of omega-3 supplementation on the nutritional status and inflammatory biomarkers in pancreatic cancer patients.", "results_summary": "Omega-3 supplementation was found to be safe, well-tolerated, and beneficial, contributing to stabilization or increase in body weight and reduction in inflammatory biomarkers. The majority of included studies were randomized controlled trials with low risk of bias.", "population_specificity": "Pancreatic cancer patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:19.858923+00:00"}
{"study_id": 201166, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether omega-3 fatty acids (EPA and DHA) could mitigate LDL-induced upregulation of WAT IL-1\u03b2 secretion and improve T2D risk factors in subjects with high-apoB.", "results_summary": "Omega-3 supplementation (EPA and DHA) abolished baseline differences in WAT IL-1\u03b2 secretion between high- and low-apoB groups, improved \u03b2-cell function and postprandial fat metabolism, and blunted associations between WAT NLRP3/IL1B expression and cardiometabolic risk factors.", "population_specificity": "Subjects with high-apoB (N=17) and low-apoB (N=16) separated around median plasma apoB.", "effective_dosage": "2.7 g/day (EPA and DHA)", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:23.385850+00:00"}
{"study_id": 201170, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to assess the effects of omega-3 fatty acids on post-exercise inflammation, muscle damage, oxidant response, and sports performance in physically healthy adults.", "results_summary": "The study found mixed results, with some biomarkers like creatine kinase (CK) and lactate dehydrogenase (LDH) showing significant changes, but no conclusive evidence on omega-3's effects on post-exercise recovery or sports performance.", "population_specificity": "Physically healthy adults", "effective_dosage": "Heterogeneous (ranging across studies)", "study_duration": "1 day to 26 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:23.597540+00:00"}
{"study_id": 201171, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the impact of omega-3 fatty acid supplementation on proteinuria levels across various kidney-related conditions.", "results_summary": "The meta-analysis found a neutral overall effect of omega-3 fatty acids on proteinuria, with no statistically significant evidence supporting efficacy. Variability in responses suggests potential individual benefits, but no definitive conclusions were drawn.", "population_specificity": "347 participants across various kidney-related conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:24.173349+00:00"}
{"study_id": 201168, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of omega-3 fatty acids on oxidative stress and inflammatory markers in patients with Type 2 diabetes mellitus (T2DM).", "results_summary": "The meta-analysis found that omega-3 fatty acids significantly decreased TNF-\u03b1 and increased TAC levels but had no beneficial effects on other markers like malondialdehyde, CRP, SOD, and IL-6. Subgroup analysis showed short-term benefits for CRP and SOD in studies lasting less than 12 weeks.", "population_specificity": "Type 2 diabetes mellitus (T2DM) patients", "effective_dosage": "Not specified", "study_duration": "Varied (subgroup analysis noted effects in studies <12 weeks)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:24.675804+00:00"}
{"study_id": 201167, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore racial differences in the cardioprotective effects of n-3 HUFA supplementation, specifically focusing on myocardial infarction (MI), stroke, and cardiovascular disease (CVD) mortality.", "results_summary": "The study found that n-3 HUFA supplementation significantly reduced MI risk in African American individuals (OR 0.17) but showed no such effect in non-Hispanic White individuals. The results suggest potential racial disparities in the efficacy of n-3 HUFA supplementation for cardiovascular outcomes.", "population_specificity": "African American (AfAm) and non-Hispanic White (NHW) individuals from the VITAL trial.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:25.539916+00:00"}
{"study_id": 201172, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine whether omega-3 fatty acids could modulate microglial phagocytosis of extracellular Tau by influencing actin-binding protein activation and cortical actin remodeling.", "results_summary": "The study hypothesized that omega-3 fatty acids may enhance microglial phagocytosis of Tau by regulating actin-binding protein activation and extracellular matrix interactions, potentially improving clearance of pathological Tau aggregates. However, experimental results or direct evidence of efficacy were not provided in the abstract.", "population_specificity": "Not specified (likely in vitro or animal models based on context).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:25.671628+00:00"}
{"study_id": 201173, "supplement_id": 1396, "safety_score": "85", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the dose-dependent effect of omega-3 fatty acid supplementation on anxiety symptoms in adults.", "results_summary": "The study found that omega-3 supplementation at 2 g/d showed the greatest improvement in anxiety symptoms, with a moderate decrease overall. No significant increase in adverse events was observed.", "population_specificity": "Adults with anxiety symptoms (2189 participants across 23 trials).", "effective_dosage": "2 g/day (greatest improvement), with doses lower than 2 g/day showing no effect.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:27.750517+00:00"}
{"study_id": 201174, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the efficacy of Omega-3 fatty acid supplementation on markers of inflammation and endothelial function in patients with chronic heart disease (CHD).", "results_summary": "Omega-3 supplementation significantly reduced levels of IL-6, hs-CRP, and TNF-\u03b1 and improved endothelial function (measured by FMD) in CHD patients. The effects were statistically significant and clinically meaningful.", "population_specificity": "Patients with chronic heart disease (mean age 58 \u00b1 10.3 years).", "effective_dosage": "Daily supplement (specific dosage not mentioned).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:28.382836+00:00"}
{"study_id": 201176, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the progression of omega-3 fatty acids research using bibliometric analysis to identify trends, influential studies, and future research directions.", "results_summary": "The study found that omega-3 fatty acids research is extensive, with the United States, China, and Spain leading in publications. There is ongoing debate about their benefits for illnesses, and future research may focus on their impact on gut microbiota.", "population_specificity": "Not specified (bibliometric analysis of published literature)", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:31.801462+00:00"}
{"study_id": 201181, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of marine-derived omega-3 fatty acid supplementation on serum levels of adhesion molecules (VCAM-1, ICAM-1, E-selectin, and P-selectin).", "results_summary": "Omega-3 supplementation significantly reduced VCAM-1 levels, showed a non-significant trend toward reducing ICAM-1 and P-selectin levels, and had no effect on E-selectin.", "population_specificity": "3,555 participants aged 18\u201375 years.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:31.970379+00:00"}
{"study_id": 201180, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the dose-dependent effects of omega-3 fatty acids supplementation on inflammatory factors in cancer patients.", "results_summary": "The study found that each 1 g/day of omega-3 fatty acids (oral/enteral) significantly reduced interleukin-6 (IL-6) levels, with a standardized mean difference of -1.17 pg/ml. The analysis included 33 randomized controlled trials involving 2068 participants.", "population_specificity": "Cancer patients", "effective_dosage": "1 g/day (oral/enteral)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:32.972508+00:00"}
{"study_id": 201185, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "To investigate the effects of omega-3 fatty acids on flow-mediated dilatation (FMD) and carotid intima-media thickness (CIMT) and explore factors influencing these effects.", "results_summary": "Omega-3 fatty acids significantly improved FMD, particularly in subgroups with CHD or CHD risk factors, but had no significant effect on CIMT. Further research is needed on CIMT effects.", "population_specificity": "Patients with CHD and patients with risk factors for CHD.", "effective_dosage": "EPA + DHA < 1 g/day and \u2265 1 g/day.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:33.887236+00:00"}
{"study_id": 201187, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of omega-3 supplementation on BDNF levels.", "results_summary": "Omega-3 supplementation significantly increased BDNF levels, with greater effects observed in interventions lasting >10 weeks, doses \u22641500 mg/day, and individuals under 50 years old.", "population_specificity": "Individuals in controlled trials, with a noted stronger effect in those under 50 years old.", "effective_dosage": "\u22641500 mg/day", "study_duration": ">10 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:33.960528+00:00"}
{"study_id": 201186, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of omega-3 fatty acid supplementation to influence anabolic or catabolic pathways in skeletal muscle and mitigate age-related sarcopenia.", "results_summary": "Omega-3 fatty acids may modify pathophysiological pathways linked to sarcopenia, but they likely need to be combined with other anabolic interventions for effective amelioration. The review highlights mechanisms from cell culture, animal, and human studies but notes mixed or incomplete evidence.", "population_specificity": "Older adults (focus on sarcopenia-related muscle loss).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:34.079001+00:00"}
{"study_id": 201188, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of omega-3 fatty acid supplementation in reducing circulating inflammatory cytokines in patients with heart failure.", "results_summary": "The meta-analysis showed a beneficial effect of omega-3 fatty acid supplementation on lowering serum TNF-a levels, with a significant standardized mean difference. The study included 10 RCTs, focusing on inflammatory markers like TNF-a, IL-6, and CRP.", "population_specificity": "Patients with heart failure (HF).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:36.354855+00:00"}
{"study_id": 201189, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether omega-3 fatty acids reduce subthreshold depressive symptoms, particularly in individuals experiencing frequent social stress.", "results_summary": "Omega-3 supplementation reduced depressive symptoms in overweight or obese individuals experiencing frequent hostile interactions and social tension, with 2.5 g/d showing additional benefits for those with less social recognition or more performance pressure. The effects were linked to reduced inflammatory reactivity to social stressors.", "population_specificity": "Healthy, sedentary, generally overweight middle-aged and older adults (N=138).", "effective_dosage": "1.25 g/d and 2.5 g/d of omega-3.", "study_duration": "4 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:38.190511+00:00"}
{"study_id": 201190, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of omega-3 fatty acids as an adjunctive therapy for COVID-19 treatment compared to control or placebo.", "results_summary": "The study found no significant benefit of omega-3 fatty acids in reducing mortality or improving other efficacy indices in COVID-19 patients, with major limitations noted in its use for treatment.", "population_specificity": "COVID-19 patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:38.966906+00:00"}
{"study_id": 201191, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the efficacy of omega-3 fatty acids supplementation on inflammatory and anti-inflammatory markers in patients with episodic migraines.", "results_summary": "Omega-3 supplementation significantly increased anti-inflammatory IL-4 levels and reduced pro-inflammatory IFN-\u03b3 levels compared to placebo, but no significant changes were observed in TGF-\u03b2 and IL-17 levels.", "population_specificity": "40 patients prone to episodic migraines.", "effective_dosage": "600 mg EPA and 300 mg DHA, twice daily.", "study_duration": "2 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:39.506361+00:00"}
{"study_id": 201192, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore how novel drug delivery approaches could improve the stability and therapeutic effectiveness of omega-3 fatty acids.", "results_summary": "The study highlights that omega-3 fatty acids have therapeutic potential against various diseases but face challenges like oxidation and poor compliance due to taste and swallowing difficulties. Novel drug delivery methods are proposed to enhance their bioavailability and efficacy.", "population_specificity": "Not specified (general discussion, no specific population studied).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:40.976595+00:00"}
{"study_id": 201193, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether omega-3 supplementation could improve glucose and lipid metabolism, insulin resistance, and inflammatory factors in individuals with gestational diabetes mellitus (GDM).", "results_summary": "Omega-3 supplementation reduced fasting plasma glucose, fasting insulin, insulin resistance, triglycerides, and inflammatory markers while increasing high-density lipoprotein cholesterol in GDM patients.", "population_specificity": "Individuals with gestational diabetes mellitus (GDM)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:41.461966+00:00"}
{"study_id": 201194, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine if genetic differences, specifically LT-\u03b1 polymorphisms, could predict individual responses to omega-3 fatty acids in attenuating inflammation.", "results_summary": "The study found that omega-3's anti-inflammatory effects vary by individual, with LT-\u03b1 genotype influencing response rates. Genetic testing may help predict who benefits most from omega-3 supplementation.", "population_specificity": "Various ethnicities (analyzed via NIH dbSNP data) with potential inflammatory conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:42.016511+00:00"}
{"study_id": 201195, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 80, "study_goal": "The researchers aimed to determine if omega-3 PUFA supplementation during pregnancy reduces the risk of eczema or IgE-associated eczema in children of different ages.", "results_summary": "The study found no significant reduction in overall eczema incidence (RR = 1.09, p = 0.54) or IgE-associated eczema (RR = 0.67, p = 0.34) in children. However, a subgroup analysis showed a significant decrease in IgE-associated eczema among children aged \u22643 years (RR = 0.70, p = 0.03).", "population_specificity": "Pregnant women and their children (1,646 mother-infant pairs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:43.296274+00:00"}
{"study_id": 201196, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether supplementation with omega-3 fatty acids, along with multivitamins and minerals, reduces aggressive incidents in individuals with intellectual disabilities or borderline intellectual functioning.", "results_summary": "The study found no significant difference in the mean number of aggressive incidents per day between the supplement and placebo groups (rate ratio = 0.93, 95% CI = 0.59-1.45). The COVID-19 pandemic may have influenced the results.", "population_specificity": "Individuals with intellectual disabilities or borderline intellectual functioning, aged 12-40 years, exhibiting aggressive behavior.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:45.320224+00:00"}
{"study_id": 201197, "supplement_id": 1396, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and safety of omega-3 fatty acids supplements in preventing cardiovascular disease through a systematic review and meta-analysis of randomized controlled trials.", "results_summary": "Omega-3 fatty acids reduced major cardiovascular events, myocardial infarction, and cardiovascular death but increased atrial fibrillation risk. No significant differences were found for heart failure, stroke, all-cause death, or safety endpoints like gastrointestinal issues, bleeding disorders, or cancer.", "population_specificity": "Patients with cardiovascular disease or risk factors, as well as those without cardiovascular disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:47.000632+00:00"}
{"study_id": 201199, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether daily Calanus oil (rich in omega-3 fatty acids) supplementation improves maximal oxygen uptake (VO2max) in healthy adults aged 30-50.", "results_summary": "The study found no significant differences in VO2max or clinical measures between the Calanus oil and placebo groups after 6 months of supplementation, indicating no effect on exercise performance.", "population_specificity": "Healthy, physically fit, normal to overweight men and women aged 30-50.", "effective_dosage": "2 g/day", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:47.543438+00:00"}
{"study_id": 201198, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of Omega-3 on CRP change and CRP levels in patients with COVID-19 to assess its potential anti-inflammatory benefits.", "results_summary": "Omega-3 significantly reduced CRP levels compared to the control group, with a mean difference of -2.53 for CRP change from baseline and -6.24 for CRP serum levels at the end of the study, indicating anti-inflammatory effects in COVID-19 patients.", "population_specificity": "Patients with COVID-19", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:47.697216+00:00"}
{"study_id": 201200, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of omega-3 fatty acids and other dietary interventions in moderating aggressive behavior, with a focus on the gut microbiome as a mediating mechanism.", "results_summary": "The study synthesizes evidence suggesting that omega-3 fatty acids and other nutritional supplements may influence aggression, though the exact mechanisms remain unclear. It highlights the potential of dietary interventions to impact behavior via the microbiota-gut-brain axis.", "population_specificity": "Not specified (review of animal and human studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:49.038514+00:00"}
{"study_id": 201204, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether omega-3 fatty acids as an adjunct to non-surgical periodontal therapy (SRP) improve probing pocket depth (PPD) and clinical attachment level (CAL) in patients with chronic periodontitis.", "results_summary": "The meta-analysis found that omega-3 fatty acids as an adjunct to SRP resulted in significantly greater PPD reduction (0.39 mm) and CAL gain (0.41 mm) compared to SRP alone, indicating a moderate but clinically meaningful added benefit.", "population_specificity": "Patients with chronic periodontitis.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:52.861386+00:00"}
{"study_id": 201203, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to assess the effect of omega-3 fatty acids (as part of a nutraceutical supplement) on metabolic, inflammatory, and antioxidant parameters in pregnant women with gestational diabetes mellitus (GD).", "results_summary": "The study found no statistically significant differences between the nutraceutical supplement group (containing omega-3 fatty acids) and the placebo group in metabolic, inflammatory, or antioxidant parameters. However, higher triglyceride levels and AA/EPA ratios were associated with increased inflammation and a greater need for pharmacological treatment in GD patients.", "population_specificity": "Pregnant women with gestational diabetes mellitus at 24-28 weeks of gestation.", "effective_dosage": "Not specified (part of a combined nutraceutical supplement).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:53.277161+00:00"}
{"study_id": 201205, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of omega-3 fatty acids in treating pediatric nonalcoholic fatty liver disease (NAFLD) by analyzing changes in liver biochemistry, BMI, and ultrasonographic steatosis.", "results_summary": "Omega-3 supplementation significantly reduced serum transaminases, improved liver steatosis on ultrasonography, and decreased BMI in children with NAFLD compared to placebo. The study suggests omega-3 fatty acids are an effective alternative treatment for pediatric NAFLD.", "population_specificity": "Children with nonalcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:54.498750+00:00"}
{"study_id": 201206, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether omega-3 fatty acid supplementation improves cognitive performance and whether APOE genotype or age modifies these effects.", "results_summary": "Omega-3 supplementation did not significantly improve cognitive performance in healthy adults overall, but individuals with low episodic memory scores showed significant improvement. APOE status and age did not modify the outcomes.", "population_specificity": "Healthy adults aged 20 to 80 years (n = 193).", "effective_dosage": "2.5 g/day of n-3 PUFA.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:54.718487+00:00"}
{"study_id": 201207, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the potential protective effects of maternal omega-3 fatty acid supplementation against adverse pregnancy outcomes linked to periodontal disease.", "results_summary": "Animal studies suggest omega-3 fatty acids may protect the fetus by reducing inflammation and bacterial proliferation in the placenta, though human interventional studies on periodontal therapy show mixed results.", "population_specificity": "Pregnant individuals (animal studies referenced, human epidemiological and interventional studies reviewed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:55.121844+00:00"}
{"study_id": 201208, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the impact of dietary omega-3 fatty acids as an adjunct to non-surgical periodontal treatment on clinical periodontal parameters in periodontitis patients.", "results_summary": "The study found that omega-3 fatty acid supplementation significantly improved clinical attachment level (CAL) and probing pocket depth (PPD) compared to periodontal treatment alone, with pooled estimates showing a PPD reduction of 0.42 mm and CAL gain of 0.58 mm.", "population_specificity": "Individuals with periodontitis undergoing non-surgical periodontal treatment.", "effective_dosage": "Not specified in the abstract.", "study_duration": "At least 3 months of follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:56.634534+00:00"}
{"study_id": 201209, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the efficacy of an omega-3 fatty acid-enriched oral nutrition supplement (ONS) on improving nutritional status, quality of life, and pro-inflammatory indices in gastrointestinal cancer patients undergoing therapy.", "results_summary": "The ONS intervention improved Patient-Generated Subjective Global Assessment (PG-SGA) scores and certain quality-of-life metrics (e.g., fatigue, role functioning) but did not significantly affect biochemical markers of nutritional status or pro-inflammatory cytokines.", "population_specificity": "Patients diagnosed with gastrointestinal cancers undergoing cancer therapy.", "effective_dosage": "200 ml ONS twice a day.", "study_duration": "8 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:55:57.316593+00:00"}
{"study_id": 201210, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to review the effects of omega-3 supplementation on lean body mass in cancer patients, with secondary objectives evaluating its impact on BMI and body weight.", "results_summary": "Omega-3 fatty acids increased lean body mass by 0.17 kg compared to placebo, but the difference was not statistically significant. Four out of fourteen studies showed significant results for lean body mass improvement.", "population_specificity": "Cancer patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:01.106452+00:00"}
{"study_id": 201211, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of omega-3 fatty acids in preventing and alleviating symptoms of VDT-associated dry eye disease (DED).", "results_summary": "Omega-3 supplementation was found to improve signs and symptoms of VDT-associated DED, acting on different parts of the dry eye disease cycle. The study suggests it could complement other preventive measures like blink animation programs and ergonomic improvements.", "population_specificity": "Video display terminal (VDT) users experiencing dry eye disease (DED).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:01.612412+00:00"}
{"study_id": 201212, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to determine whether omega-3 fatty acid supplementation could reduce pruritus in hemodialysis patients with chronic kidney disease-associated pruritus.", "results_summary": "Omega-3 supplementation significantly reduced pruritus scores compared to placebo, but no significant difference was observed in prostaglandin E2 levels between the intervention and placebo groups.", "population_specificity": "Hemodialysis patients with chronic kidney disease-associated pruritus (n=40).", "effective_dosage": "3 grams per day.", "study_duration": "4 weeks per treatment period (with a 6-week washout period).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:02.568894+00:00"}
{"study_id": 201214, "supplement_id": 1396, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effectiveness of omega-3 fatty acids in reducing the risk of prematurity in well-nourished women with access to high-quality obstetric care and to assess the translation of evidence into policy and practice.", "results_summary": "Omega-3 supplementation reduces the risk of early preterm birth in women with a singleton pregnancy and low omega-3 status, while avoiding unnecessary supplementation for those who are replete prevents potential harm.", "population_specificity": "Well-nourished women with singleton pregnancies and low omega-3 status, with access to high-quality obstetric care.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:03.944315+00:00"}
{"study_id": 201216, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of long-term omega-3 PUFA supplementation on circulating microvesicle release in elderly subjects at very high risk of cardiovascular disease.", "results_summary": "The study found no significant differences in prothrombotic microvesicle release between the omega-3 PUFA and placebo groups after one year of supplementation, indicating no modulation of vascular effects.", "population_specificity": "Elderly Norwegians who recently suffered an acute myocardial infarction.", "effective_dosage": "930 mg EPA + 660 mg DHA daily.", "study_duration": "Two years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:05.780986+00:00"}
{"study_id": 201215, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether omega-3 LCPUFA supplementation selectively suppresses pro-inflammatory monocytes and their cytokines in patients with Duchenne muscular dystrophy (DMD).", "results_summary": "Omega-3 LCPUFA supplementation increased anti-inflammatory monocytes at month 3 and reduced pro-inflammatory monocytes and their cytokine interleukin-6 at months 3 and 6 compared to placebo. The findings suggest a selective reductive effect on pro-inflammatory monocytes in DMD patients.", "population_specificity": "Patients with Duchenne muscular dystrophy (DMD) (n=12, split into omega-3 and placebo groups).", "effective_dosage": "Not specified in the abstract.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:05.851028+00:00"}
{"study_id": 201217, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of oxidative stress in cardiac diseases and evaluate the potential benefits of omega-3 fatty acids as an experimental treatment.", "results_summary": "The abstract highlights that omega-3 fatty acids, among other treatments, may offer benefits in managing oxidative stress-related cardiovascular disorders, though specific results are not detailed.", "population_specificity": "Not specified (general cardiovascular pathophysiology context).", "effective_dosage": "Not available.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:08.757130+00:00"}
{"study_id": 201218, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of omega-3 PUFA-enriched oral nutritional supplements on nutritional status and clinical outcomes in patients undergoing chemo (radio) therapy.", "results_summary": "The meta-analysis found a significant increase in body weight and BMI, suggesting potential benefits of omega-3 supplementation during cancer therapy. However, evidence for broader clinical outcomes remains limited.", "population_specificity": "Patients undergoing chemo (radio) therapy (1,155 participants across 22 studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:09.755886+00:00"}
{"study_id": 201219, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to clarify the effects of Omega-3 fatty acid supplementation on patients with COPD by analyzing randomized controlled trials.", "results_summary": "Omega-3 intake was associated with increased weight, higher LDL levels, and reduced IL-6 levels, though the evidence quality and quantity were limited. No significant effects were found in other measured domains.", "population_specificity": "418 patients with COPD (mean age 67.3 years).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:10.181781+00:00"}
{"study_id": 201220, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine if omega-3 fatty acids as an adjunct therapy could reduce renal scar formation after acute pyelonephritis in pediatric patients.", "results_summary": "The study found that omega-3 fatty acids, when combined with standard antibiotic treatment, significantly reduced renal scarring when both kidneys were considered together, though results for individual kidneys were not statistically significant.", "population_specificity": "60 children with acute pyelonephritis in a tertiary hospital in Iran.", "effective_dosage": "Oral omega-3 fatty acids based on the children's weight for three consecutive days.", "study_duration": "3 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:12.136452+00:00"}
{"study_id": 201221, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effects of omega-3 fatty acids on lowering blood triglycerides and preventing heart disease.", "results_summary": "The study found that omega-3 fatty acids lower blood triglycerides, but their effectiveness in preventing heart disease is less clear. The abstract does not provide specific data on the magnitude of these effects.", "population_specificity": "Not specified (general population implied, but not detailed).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:13.029917+00:00"}
{"study_id": 201222, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of daily omega-3 fatty acid supplementation on cerebrospinal fluid biomarkers in Alzheimer's disease patients and explore potential correlations with cognitive performance.", "results_summary": "Omega-3 supplementation led to a small but significant increase in YKL-40 and NfL biomarkers, suggesting possible inflammatory response and axonal damage, but did not correlate with cognitive test scores. Other biomarkers remained stable.", "population_specificity": "33 patients diagnosed with Alzheimer's disease.", "effective_dosage": "2.3 g of omega-3 fatty acids daily.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:14.729968+00:00"}
{"study_id": 201223, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of omega-3 fatty acid supplementation during pregnancy and/or lactation on neurodevelopmental outcomes in children.", "results_summary": "Limited evidence suggests omega-3 supplementation during pregnancy may improve cognitive development in children by 6%-11%, but results were inconsistent for other developmental outcomes. No sufficient evidence was found for supplementation during lactation or combined periods.", "population_specificity": "Pregnant and lactating women and their children (0-18 years), with underrepresentation of lower socioeconomic status and adolescent populations.", "effective_dosage": "200-2200 mg/d DHA and 0-1100 mg/d EPA for approximately 20 weeks.", "study_duration": "Approximately 20 weeks during pregnancy.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:18.405358+00:00"}
{"study_id": 201224, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether preoperative immunonutrition containing Omega-3 Fatty Acids reduces infectious complications and improves outcomes in colon cancer surgery patients.", "results_summary": "The study found no significant difference in infectious or total complication rates between the immunonutrition and control groups. However, the immunonutrition group showed better weight recovery after discharge compared to the control group.", "population_specificity": "Patients with primary colon cancer undergoing elective surgery.", "effective_dosage": "400 mL/day of oral nutritional supplementation containing arginine and Omega-3 Fatty Acids.", "study_duration": "7 days before surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:18.841364+00:00"}
{"study_id": 201225, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effect of omega-3 fatty acid supplementation on cardiovascular risk factors in patients with polycystic ovary syndrome (PCOS).", "results_summary": "Omega-3 fatty acid supplementation was associated with significant improvements in insulin levels, HOMA-IR, total cholesterol, triglycerides, LDL-C, VLDL-C, and HDL-C, but had no effect on serum glucose. The results were statistically significant for most outcomes, though heterogeneity was high for some measures.", "population_specificity": "Women with polycystic ovary syndrome (PCOS) (778 participants across 10 studies).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:20.065517+00:00"}
{"study_id": 201226, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the role of nutrition and omega-3 supplementation in pediatric oncology, focusing on its potential benefits and anti-tumoral properties.", "results_summary": "The study summarizes evidence supporting the importance of adequate nutrition in childhood cancer and highlights the potential benefits of omega-3 supplementation, including possible effects on nutritional status and chemotherapy outcomes. Further large-scale trials are needed to confirm anti-cancer effects.", "population_specificity": "Children with cancer (pediatric oncology patients).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:20.455163+00:00"}
{"study_id": 201227, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether omega-3 fatty acid supplementation during pregnancy reduces the risk of preterm birth (PTB) and early preterm birth (ePTB).", "results_summary": "The study found an initial 11% reduction in PTB risk and a 27% reduction in ePTB risk with omega-3 supplementation, but after sensitivity analyses, these differences were no longer statistically significant. The authors concluded that omega-3 supplementation does not significantly reduce PTB or ePTB risk.", "population_specificity": "Pregnant women", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:22.420188+00:00"}
{"study_id": 201228, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of marine omega-3 fatty acid supplements on heart failure hospitalization, recurrent hospitalization, and cardiovascular mortality in patients with heart failure.", "results_summary": "Omega-3 supplementation did not reduce first HF hospitalization or cardiovascular mortality but significantly reduced recurrent HF hospitalizations compared to placebo.", "population_specificity": "Patients with heart failure", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:23.518572+00:00"}
{"study_id": 201229, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of omega-3 fatty acids supplements on adipokines, specifically adiponectin and leptin levels.", "results_summary": "Omega-3 fatty acids intake significantly increased plasma adiponectin levels but did not impact leptin concentrations. Larger, well-designed RCTs are still needed to assess effects on leptin in specific diseases.", "population_specificity": "4,568 participants across 52 trials (no specific population details provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:26.869903+00:00"}
{"study_id": 201230, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the impact of omega-3 fatty acids supplementation on cardiometabolic outcomes and oxidative stress parameters in patients with chronic kidney disease (CKD).", "results_summary": "Omega-3 fatty acids supplementation significantly decreased total cholesterol (TC) but did not show consistent effects on other cardiometabolic outcomes or oxidative stress parameters. The results were mixed, with some benefits observed but not across all measured outcomes.", "population_specificity": "Patients with chronic kidney disease (CKD).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:27.886109+00:00"}
{"study_id": 201233, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the clinical effects of omega-3 fatty acids supplementation on cardiovascular outcomes by analyzing previous randomized controlled trials and observational cohort studies.", "results_summary": "The study found that omega-3 fatty acids supplementation was associated with a significant reduction in total mortality from major cardiovascular causes, with consistent results in large-scale RCTs. However, conflicting results across studies indicate the need for further verification of clinical benefits.", "population_specificity": "Patients in randomized controlled trials and observational cohort studies, including large-scale trials with over 1,000 participants.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:29.721783+00:00"}
{"study_id": 201234, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 65, "study_goal": "The researchers aimed to review the effectiveness of nutritional supplements, including Omega-3 Fatty Acids, in reducing aggression and violence in adults.", "results_summary": "The study found mixed effects of Omega-3 Fatty Acids on aggression, with some studies reporting benefits and others showing no significant effects. Overall, results were contradictory, indicating limited and inconsistent evidence.", "population_specificity": "Adults in correctional and psychiatric settings.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:30.457515+00:00"}
{"study_id": 201232, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the mechanisms of action of omega-3 PUFAs on the haemostatic system, particularly blood platelets and endothelium, and evaluate epidemiological and clinical trial data on their cardioprotective effects.", "results_summary": "The study found mixed results regarding the benefits of omega-3 PUFAs, with some studies failing to show positive effects. The authors suggest higher doses and proper omega-3 to omega-6 ratios may be needed, and highlight potential anti-thrombotic properties as a promising area for future research.", "population_specificity": "Not specified (general review of existing studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:31.284322+00:00"}
{"study_id": 201235, "supplement_id": 1396, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the absorption and side effects of Omega-3 fatty acids (EPA and DHA) when esterified in monoglycerides (MAGs), ethyl esters (EEs), or triglycerides (TGs).", "results_summary": "The study found that MAG-form Omega-3s had significantly higher plasma concentrations (2x higher than EEs and 1x higher than TGs) with similar side effects across all forms.", "population_specificity": "11 women and 11 men aged 18-50 years.", "effective_dosage": "Single oral dose of ~1.2 g EPA and DHA.", "study_duration": "24-hour follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:33.377977+00:00"}
{"study_id": 201236, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether omega-3 fatty acids (1 g/day) supplementation, in combination with vitamin D3, affects weight, BMI, or body composition in older adults.", "results_summary": "The abstract does not report specific results for omega-3 fatty acids, focusing instead on vitamin D3's lack of effect on weight or body composition.", "population_specificity": "771 US adults (men \u226550 and women \u226555 years).", "effective_dosage": "1 g/day", "study_duration": "2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:35.539247+00:00"}
{"study_id": 201201, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the efficacy of n-3 PUFAs supplementation on inflammatory biomarkers in adults with various health conditions through an umbrella meta-analysis.", "results_summary": "The study found that n-3 PUFA supplementation significantly reduced serum CRP, TNF-\u03b1, and IL-6 concentrations, suggesting anti-inflammatory effects across different health conditions. The results were statistically significant and clinically relevant.", "population_specificity": "Adults with various health conditions.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:35.622339+00:00"}
{"study_id": 201237, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether marine omega-3 fatty acid supplementation could reduce migraine frequency or severity compared to placebo.", "results_summary": "The study found no significant difference in migraine frequency or severity between participants taking active omega-3 fatty acids and those taking placebo, with similar percentages reporting decreases in both groups.", "population_specificity": "Middle-aged or older adults with a history of probable migraine.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:35.734244+00:00"}
{"study_id": 201238, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to clarify the efficacy of omega-3 fatty acid supplementation in reducing mortality and improving outcomes in patients with sepsis.", "results_summary": "Omega-3 fatty acid supplementation was associated with reduced mortality in sepsis patients, particularly those with gastrointestinal dysfunction, and shortened duration of mechanical ventilation (DMV) and ICU length of stay (LOS).", "population_specificity": "Adults with sepsis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:37.784564+00:00"}
{"study_id": 201239, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "To examine the influence of omega-3 fatty acid supplementation on skeletal muscle anabolism, particularly during periods of skeletal muscle disuse.", "results_summary": "Omega-3 fatty acid supplementation during skeletal muscle disuse increased omega-3 composition in muscle membranes, heightened muscle protein synthesis rates, and protected against muscle loss, likely due to changes in mitochondrial bioenergetics.", "population_specificity": "Individuals experiencing skeletal muscle disuse (specific population not further detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:38.844280+00:00"}
{"study_id": 201240, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the additive effects of omega-3 fatty acids supplements, combined with exercise and protein, on preventing loss of skeletal muscle mass and function in sarcopenic older adults.", "results_summary": "The study evaluated changes in physical performance, muscle mass, strength, and function, but specific results for omega-3 fatty acids alone were not detailed in the abstract. Compliance with omega-3 supplementation was objectively measured via red blood cell membrane analysis.", "population_specificity": "Sarcopenic older adults (\u2265 65 years) living in the community.", "effective_dosage": "Not specified in the abstract.", "study_duration": "12-week intervention period followed by a 12-week follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:40.198712+00:00"}
{"study_id": 201241, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to examine the efficacy of EPA/DHA supplementation on performance, recovery, and injury/illness risk reduction in both athletes and amateurs.", "results_summary": "The study suggests potential benefits of EPA/DHA on endurance capacity, delayed muscle soreness, recovery markers, and immune modulation, though evidence is inconsistent and stronger in amateurs than athletes. Clear recommendations are limited due to diverse study designs and inconsistent clinical endpoint translations.", "population_specificity": "Athletes and amateurs (professionally trained vs. non-professional individuals).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:43.249081+00:00"}
{"study_id": 201243, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to review studies assessing dietary interventions, including Omega-3 Fatty Acids, for the prevention of postpartum depression (PPD) and postpartum blues.", "results_summary": "The abstract indicates that most trials on dietary and hormonal interventions for PPD prevention, including Omega-3 Fatty Acids, show preliminary, non-definitive, or variable results, with some trend-level findings. Combined interventions may be more promising than monotherapies.", "population_specificity": "Childbearing women, particularly those at high risk for postpartum depression.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:44.402226+00:00"}
{"study_id": 201244, "supplement_id": 1396, "safety_score": "85", "efficacy_score": 30, "quality_score": 90, "study_goal": "The researchers aimed to determine whether omega-3 fatty acids, alone or in combination with vitamin D3 and exercise, improved six health outcomes (blood pressure, physical performance, cognitive function, fracture incidence, and infection rates) in older adults.", "results_summary": "The study found no statistically significant benefits of omega-3s alone or in combination for any of the six primary outcomes, including blood pressure, physical performance, cognitive function, fracture incidence, or infection rates. The differences in outcomes were minimal and not clinically meaningful.", "population_specificity": "Adults aged 70 years or older without major comorbidities, with sufficient mobility and good cognitive status.", "effective_dosage": "1 g/d of omega-3s", "study_duration": "3 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:45.352009+00:00"}
{"study_id": 201242, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether omega-3 fatty acids (1 g/d) supplementation, alongside vitamin D, could reduce the incidence of advanced (metastatic or fatal) cancer and examine potential effect modification by BMI.", "results_summary": "The study found no significant differences in cancer incidence by treatment arm for omega-3 fatty acids. The primary focus was on vitamin D's effects, with limited discussion of omega-3 outcomes.", "population_specificity": "Men aged 50+ and women aged 55+ in the U.S., free of cancer and cardiovascular disease at baseline.", "effective_dosage": "1 g/d of marine omega-3 fatty acids.", "study_duration": "Median intervention period of 5.3 years (range, 3.8-6.1 years).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:45.565832+00:00"}
{"study_id": 201245, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of omega-3 fatty acids on systemic lupus erythematosus (SLE) disease activity in adults through a systematic review and meta-analysis.", "results_summary": "Omega-3 fatty acids reduced SLE disease activity with a moderate effect size (SMD -0.33) and low certainty evidence, translating to a reduction of 0.9 on the SLEDAI scale. The meta-analysis suggests potential therapeutic benefits when added to standard immunosuppressive regimens.", "population_specificity": "Adults with SLE, predominantly female (\u226580%), mean age 43 years.", "effective_dosage": "\u22643 g of omega-3 fatty acids.", "study_duration": "12 to 52 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:46.958544+00:00"}
{"study_id": 201246, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 85, "study_goal": "The researchers aimed to determine whether omega-3 fatty acid supplementation prior to stroke reduces the risk of functional limitations and physical disability after stroke.", "results_summary": "The study found no significant improvement in post-stroke outcomes with omega-3 fatty acid supplementation, though there was a non-significantly lower risk of functional limitations and physical disability.", "population_specificity": "Middle-aged and older men and women without prior cardiovascular disease.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Median follow-up of 1.4 years after stroke diagnosis.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:47.353289+00:00"}
{"study_id": 201247, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether daily supplementation with marine \u03c9-3 fatty acids prevents the development or progression of age-related macular degeneration (AMD).", "results_summary": "The study found no significant overall effect of marine \u03c9-3 fatty acid supplementation on AMD incidence or progression, with hazard ratios close to 1.0 for both incident AMD and AMD progression.", "population_specificity": "25,871 men and women in the US, mean age 67.1 years, 50.6% women, 71.3% non-Hispanic White, 20.2% Black.", "effective_dosage": "1 g per day of marine \u03c9-3 fatty acids.", "study_duration": "Median 5.3 years (range 3.8-6.1 years).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:50.622111+00:00"}
{"study_id": 201248, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of statin use and omega-3 supplementation on all-cause mortality and CVD death in primary, secondary, and mixed prevention populations.", "results_summary": "Omega-3 supplementation showed a borderline effect on all-cause mortality but significantly reduced CVD death risk. Statins were more effective than omega-3s in lowering all-cause mortality, but differences in CVD death reduction were borderline or nonsignificant across populations.", "population_specificity": "Primary, secondary, and mixed prevention populations for cardiovascular disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:51.743214+00:00"}
{"study_id": 201249, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the use of omega-3 PUFAs as an adjuvant therapy in treating inflammatory buccal diseases.", "results_summary": "Omega-3 PUFAs reduced pro-inflammatory mediators in gingivitis and periodontitis, suppressed bone resorption in apical periodontitis and orthodontic movement, and alleviated painful symptoms in recurrent aphthous stomatitis.", "population_specificity": "Individuals with gingivitis, periodontitis, apical periodontitis, stomatitis, and those undergoing orthodontic tooth movement; some studies involved rats.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:52.981099+00:00"}
{"study_id": 201251, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the clinical outcomes of systemic re-esterified triglyceride (rTG) omega-3 fatty acids in reducing dry eye symptoms after cataract surgery.", "results_summary": "Omega-3 supplementation improved subjective symptom scores (OSDI and DEQ) and reduced ocular surface inflammation (lower MMP-9 levels) compared to the control group, though tear secretion parameters did not significantly change.", "population_specificity": "66 patients with new-onset non-specific dry eye symptoms one month after uncomplicated cataract surgery.", "effective_dosage": "Not specified", "study_duration": "2 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:54.143514+00:00"}
{"study_id": 201250, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the cardiovascular benefits of high-dose EPA (omega-3 fatty acids) in reducing major cardiovascular events in patients with elevated triglyceride levels.", "results_summary": "High-dose EPA (4 g/day) significantly reduced major cardiovascular events in patients with elevated triglycerides, with benefits exceeding those expected from triglyceride reduction alone. The effect may involve mechanisms beyond lipid-lowering, such as reduced inflammation and platelet aggregation.", "population_specificity": "High/very-high cardiovascular risk patients with mild-to-moderate hypertriglyceridaemia on optimal LDL-C-lowering therapy.", "effective_dosage": "4 g/day EPA", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:54.631458+00:00"}
{"study_id": 201252, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether omega-3 supplementation, in combination with exercise training, reduces inflammation in adipose tissue and improves metabolic health in older women.", "results_summary": "Omega-3 supplementation combined with exercise training did not show additional benefits on adipose tissue inflammation compared to exercise alone. Trained women had lower inflammation markers, but omega-3 did not enhance these effects.", "population_specificity": "Older women (71 \u00b1 4 years, n = 55 in the intervention group).", "effective_dosage": "Not specified (Calanus oil was used).", "study_duration": "4 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:55.665447+00:00"}
{"study_id": 201253, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the efficacy of combined omega-3 and Korean red ginseng supplementation on ADHD symptoms and cognitive function in children with subthreshold ADHD.", "results_summary": "The study found significant improvements in ADHD-RS scores and several CBCL subscales, including ADHD and attention problem subscales, suggesting beneficial effects of the combined supplementation.", "population_specificity": "Children aged 6-12 years with subthreshold ADHD.", "effective_dosage": "Not available", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:56:56.179658+00:00"}
{"study_id": 201254, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "To investigate the effects of omega-3 fatty acids combined with punctal plugs on tear film and ocular surface parameters in patients receiving systemic isotretinoin therapy.", "results_summary": "The combination of omega-3 fatty acids and punctal plugs improved ocular surface parameters compared to the isotretinoin-only group, with no significant differences between the punctal plugs alone and the combination group except for meibomian gland expression. The isotretinoin group showed worsening of ocular surface parameters.", "population_specificity": "90 patients (180 eyes) receiving systemic isotretinoin therapy (120-150 mg/kg for at least 4-6 months) without pre-existing dry eye disease.", "effective_dosage": "1040 mg/day (two capsules twice daily)", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:02.025010+00:00"}
{"study_id": 201255, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the impact of short-term oral enriched marine oil supplementation on leukocyte phenotype and biochemical mediators in patients with symptomatic PAD and healthy volunteers.", "results_summary": "The study found that supplementation significantly increased plasma levels of pro-resolving lipid mediators, enhanced phagocytic activity of immune cells, and reduced proinflammatory markers, particularly in PAD patients. The results suggest a shift toward a less inflammatory and more reparative immune phenotype.", "population_specificity": "10 healthy volunteers and 10 patients with symptomatic peripheral artery disease (PAD).", "effective_dosage": "3 escalating doses (specific amounts not detailed in the abstract).", "study_duration": "5 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:02.310749+00:00"}
{"study_id": 201256, "supplement_id": 1396, "safety_score": "65", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the cardiovascular benefits of different doses of Omega-3 fatty acid (O3FA) supplementation through pairwise and network meta-analysis.", "results_summary": "High-dose O3FA (>1 g/day) was associated with reduced risks of cardiac death, myocardial infarction, coronary revascularization, unstable angina, and major vascular events but increased risks of bleeding and atrial fibrillation compared to low-dose and control groups.", "population_specificity": "125,763 patients across 14 studies.", "effective_dosage": "Low-dose (<1 g/day), high-dose (>1 g/day).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:02.655136+00:00"}
{"study_id": 201257, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effect of omega-3 fatty acids on cardiovascular outcomes, focusing on dosage, type of omega-3, and baseline cardiovascular risk.", "results_summary": "Omega-3 supplementation significantly reduced cardiac mortality, MACE, and MI, particularly in secondary prevention patients. Higher doses (>1 g/day) and EPA alone showed greater efficacy in reducing specific cardiovascular risks compared to combined EPA+DHA.", "population_specificity": "Subjects with previous cardiovascular events.", "effective_dosage": "\u22651 g/day of n-3 PUFA.", "study_duration": "\u22651 year.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:02.772651+00:00"}
{"study_id": 201258, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Omega-3 fatty acids (n-3 FA) supplementation reduces knee pain, improves function, or alleviates stiffness in adults with chronic knee pain.", "results_summary": "The study found no significant difference in WOMAC pain, function, or stiffness scores between the active n-3 FA group and the placebo group over a mean follow-up of 5.3 years, indicating no therapeutic benefit.", "population_specificity": "US adults (mean age 67.7 years, 66% women) with chronic knee pain.", "effective_dosage": "Not specified", "study_duration": "Mean 5.3 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:03.674820+00:00"}
{"study_id": 201260, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether daily supplementation with omega-3 fatty acids (1 g/day) affects fall risk in generally healthy older adults.", "results_summary": "The abstract does not report specific results for omega-3 fatty acids, focusing instead on vitamin D3 supplementation, which showed no significant effect on fall risk.", "population_specificity": "Men aged 50+ and women aged 55+ without cancer or cardiovascular disease at baseline (mean age: 67.1 years).", "effective_dosage": "1 g/day", "study_duration": "5.3 years (median)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:03.842575+00:00"}
{"study_id": 201259, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether maternal intake of omega-3 fatty acids during pregnancy influences the risk of allergic outcomes (asthma/wheeze, allergic rhinitis, AD, food allergies) in offspring.", "results_summary": "Omega-3 fatty acids showed a non-significant trend toward reducing the risk of asthma/wheeze (OR: 0.70; 95% CI: 0.45-1.08) and allergic rhinitis (OR: 0.76; 95% CI: 0.56-1.04) but had no significant effect on AD or food allergy risk.", "population_specificity": "Pregnant women and their offspring.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:05.477144+00:00"}
{"study_id": 201261, "supplement_id": 1396, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the clinical applications of omega-3 fatty acid (O3FA) supplementation in skin disease prevention and management by reviewing existing literature.", "results_summary": "The study found that O3FA supplementation showed benefits in treating psoriasis, atopic dermatitis, acne, and skin ulcers, as well as reducing skin cancer incidence and mitigating drug-associated mucocutaneous side effects. The review highlighted O3FA's high safety profile, low cost, and potential as an adjuvant therapy for inflammatory skin conditions.", "population_specificity": "Patients with dermatological conditions (psoriasis, atopic dermatitis, acne, skin ulcers) and those at risk for skin cancer or experiencing drug-associated mucocutaneous side effects.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:05.762974+00:00"}
{"study_id": 201263, "supplement_id": 1396, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to determine whether omega-3 fatty acid supplementation reduces post-operative deep vein thrombosis and pulmonary embolism in elderly patients with proximal femoral fractures.", "results_summary": "Omega-3 fatty acids significantly reduced incidences of pulmonary embolism and deep vein thrombosis, including fatal events, but did not affect other complications like haematoma evacuation or wound infections.", "population_specificity": "Elderly patients (>60 years) with proximal femoral fractures.", "effective_dosage": "1000 mg daily, oral administration.", "study_duration": "30 days post-surgery.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:09.957725+00:00"}
{"study_id": 201265, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "To investigate whether oral omega-3 fatty acids improve erythrocyte function in morbidly obese women undergoing gastric bypass surgery compared to a low-calorie diet.", "results_summary": "Omega-3 supplementation did not significantly affect erythrocyte function compared to the low-calorie diet. Both groups showed improved erythrocyte aggregability and metabolic parameters six months post-surgery.", "population_specificity": "Morbidly obese women undergoing laparoscopic Roux-en-Y gastric bypass surgery.", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:10.889273+00:00"}
{"study_id": 201266, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of omega-3 fatty acid supplementation, alone or combined with vitamin D, on inflammation and nutritional status in colorectal cancer patients.", "results_summary": "The abstract does not provide specific results regarding the effects of omega-3 fatty acids, but the study design suggests an investigation into its impact on inflammation and nutritional status.", "population_specificity": "Colorectal cancer patients", "effective_dosage": "Two 330 mg omega-3 fatty acid capsules daily", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:10.890707+00:00"}
{"study_id": 201264, "supplement_id": 1396, "safety_score": "80", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether perioperative supplementation with omega-3 fatty acids (n-3 FA) improved perioperative outcomes and survival in patients undergoing colorectal cancer surgery.", "results_summary": "The study found no significant differences in postoperative complications or 3-year disease recurrence between the n-3 FA and control groups. However, n-3 FA supplementation was associated with higher mortality after adjustment for confounding factors, with no survival benefit observed.", "population_specificity": "Patients scheduled for elective colorectal cancer surgery.", "effective_dosage": "n-3 FA-enriched oral nutrition supplement twice daily.", "study_duration": "7 days before and after surgery.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:11.399531+00:00"}
{"study_id": 201268, "supplement_id": 1396, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of omega-3 fatty acids on proteinuria, eGFR, and metabolic biomarkers in diabetic patients.", "results_summary": "Omega-3 fatty acids significantly reduced proteinuria in type 2 DM patients after at least 24 weeks of supplementation, with no significant effects on eGFR, cholesterol, or HbA1C. The effects on type 1 DM were not statistically significant.", "population_specificity": "Patients with diabetes (type 1 and type 2 DM).", "effective_dosage": "Not specified", "study_duration": "At least 24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:12.049165+00:00"}
{"study_id": 201267, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the cardiovascular benefits and safety of low-dose and high-dose Omega-3 Fatty Acids (O3FA) supplementation compared to placebo through a network meta-analysis of randomized clinical trials.", "results_summary": "The study intends to clarify the impact of O3FA on major cardiovascular events (e.g., cardiac death, myocardial infarction, stroke) and safety outcomes (e.g., bleeding, gastrointestinal disturbances, atrial fibrillation), resolving inconsistencies from prior research.", "population_specificity": "Patients with or at risk of cardiovascular events.", "effective_dosage": "Low dose (<1 g per day) and high dose (>1 g per day).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:13.059157+00:00"}
{"study_id": 201269, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether omega-3 fatty acids could counteract muscle lipotoxicity and prevent comorbidities in rheumatoid arthritis (RA) patients.", "results_summary": "The study suggests omega-3 fatty acids may prevent RA development, improve muscle metabolism, and limit muscle atrophy in obese and insulin-resistant subjects, potentially reducing cardiometabolic risks in RA patients.", "population_specificity": "Rheumatoid arthritis patients, particularly those with comorbidities like cardiovascular disorders, insulin resistance, and sarcopenia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:13.419491+00:00"}
{"study_id": 201270, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of omega-3 fatty acids on nutritional indicators, renal disease markers, and inflammatory markers in CKD patients undergoing hemodialysis.", "results_summary": "The study compared omega-3 fatty acids to paraffin oil but did not report significant differences in general characteristics or specific outcomes related to inflammatory markers or renal disease markers.", "population_specificity": "Patients with chronic kidney disease (CKD) undergoing hemodialysis.", "effective_dosage": "2.4 g (4 capsules) of omega-3 fatty acids daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:14.216118+00:00"}
{"study_id": 201274, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine how exercise training combined with omega-3 PUFA supplementation affects serum and adipose tissue lipidome in older women.", "results_summary": "The study compared exercise training alone versus combined with omega-3 PUFA (Calanus oil) but did not specify the exact effects of omega-3 in the abstract.", "population_specificity": "Sedentary older women (n=55)", "effective_dosage": "Not specified", "study_duration": "4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:18.062249+00:00"}
{"study_id": 201272, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "To review the effects of omega-3 fatty acids during childhood on allergic disease outcomes.", "results_summary": "The meta-analysis found no significant reduction in the risk of any atopy or eczema from omega-3 fatty acids during childhood, with limited evidence supporting its role in reducing allergic disease risk.", "population_specificity": "Children (\u22643 years old and 3-6 years old)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:18.420023+00:00"}
{"study_id": 201277, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to assess the effects of omega-3 fatty acids and antioxidant supplements on exercise response in older adults.", "results_summary": "Omega-3 fatty acids did not significantly affect pro-inflammatory marker levels or fat oxidation induced by exercise, but older adults taking these supplements showed improved exercise response and lower muscle damage.", "population_specificity": "Older adults", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:18.831956+00:00"}
{"study_id": 201273, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of vitamin D and omega-3 fatty acids co-supplementation on inflammatory biomarkers, tumor marker CEA, and nutritional status in colorectal cancer patients undergoing chemotherapy.", "results_summary": "The study suggests that omega-3 fatty acids may decrease inflammatory biomarkers, enhance chemotherapy efficacy, and reduce chemotherapy side effects in colorectal cancer patients, though specific results from the trial are not detailed in the abstract.", "population_specificity": "Patients with stage \u04c0\u04c0 or \u04c0\u04c0\u04c0 colorectal cancer undergoing chemotherapy.", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:19.299606+00:00"}
{"study_id": 201275, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate whether supplemental vitamin D and Omega-3 Fatty Acids reduce the risk of cancer or cardiovascular disease in a randomized trial setting.", "results_summary": "The abstract does not provide specific results regarding Omega-3 Fatty Acids' effects on cancer or cardiovascular disease risk.", "population_specificity": "Nationwide population (specific demographics not detailed in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:19.431282+00:00"}
{"study_id": 201279, "supplement_id": 1396, "safety_score": "90", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of omega-3 fatty acids in preventing or slowing the progression of neurodegenerative diseases like Parkinson's and Alzheimer's.", "results_summary": "The study found that omega-3 fatty acids have beneficial effects through anti-inflammatory mediators, cell membrane fluidity, and gene expression, suggesting their potential in managing early-stage neurodegenerative diseases.", "population_specificity": "Individuals with or at risk of neurodegenerative diseases such as Parkinson's and Alzheimer's.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:20.726704+00:00"}
{"study_id": 201280, "supplement_id": 1396, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the efficacy and safety of omega-3 fatty acids (3 g/day for 12 weeks) in treating hypertriglyceridemia in children and adolescents with obesity.", "results_summary": "Omega-3 supplementation significantly reduced triglyceride concentrations by 39.1% compared to 14.6% in the placebo group. Gastrointestinal adverse events were more common in the omega-3 group (41.2%) but no serious drug-related adverse events occurred.", "population_specificity": "Pediatric patients (10-16 years old) with obesity (BMI \u226595th percentile) and hypertriglyceridemia (triglycerides 150-1000 mg/dL).", "effective_dosage": "3 g/day", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:22.822750+00:00"}
{"study_id": 201281, "supplement_id": 1396, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of Omega-3 Fatty Acids on toxicity, side effects, body composition, cardiometabolic profile, and quality of life in women with locally advanced breast cancer undergoing neoadjuvant chemotherapy.", "results_summary": "The study found no significant differences in hematological and anthropometric toxicity parameters between the Omega-3 and placebo groups. The only significant improvement was in xerostomia (dry mouth) among patients supplemented with Omega-3.", "population_specificity": "Women with locally advanced breast cancer receiving neoadjuvant chemotherapy.", "effective_dosage": "2.4 g/day (EPA 1.6 g and DHA 0.8 g).", "study_duration": "Duration of neoadjuvant chemotherapy (specific length not stated in the abstract).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:24.435946+00:00"}
{"study_id": 201283, "supplement_id": 1396, "safety_score": "75", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to examine the effect of Omega-3 Fatty Acids on mortality, morbidity, and adverse events in patients with acute myocardial infarction (AMI).", "results_summary": "Omega-3 Fatty Acids showed little to no significant difference in all-cause mortality, cardiovascular mortality, new AMI, stroke, or cardiovascular events. Adverse events were uncertain, with no clear reduction or increase.", "population_specificity": "Adult patients with acute myocardial infarction (AMI).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:26.468563+00:00"}
{"study_id": 201282, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 85, "study_goal": "The researchers aimed to assess whether a long-term lifestyle multidomain intervention combined with omega-3 supplementation could reduce frailty level and incidence in older adults.", "results_summary": "The study found no significant differences in frailty level evolution or incidence between intervention groups and placebo. However, a sensitivity analysis suggested a potential reduction in frailty incidence with the combined intervention after excluding early incident cases.", "population_specificity": "Community-dwelling older adults aged 70+ with memory complaints, slow gait speed, or limitations in instrumental activities of daily living.", "effective_dosage": "Daily omega-3 fatty acids (specific dosage not mentioned).", "study_duration": "3 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:26.529552+00:00"}
{"study_id": 201284, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects and potential mechanisms of omega-3 PUFA supplementation in managing cancer-related complications beyond cachexia.", "results_summary": "The study suggests omega-3 PUFAs may modulate pathways involved in cancer-related complications, showing anti-inflammatory and antinociceptive effects, but concludes that further research is needed to confirm their benefits.", "population_specificity": "Cancer patients, particularly those with complications like anorexia-cachexia syndrome, pain, depression, and paraneoplastic syndromes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:27.022339+00:00"}
{"study_id": 201287, "supplement_id": 1396, "safety_score": "85", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Omega-3 Fatty Acids supplementation on inflammatory markers (IL-12, IL-18, and hsCRP) in patients with Stage 3-4 chronic kidney disease.", "results_summary": "Omega-3 Fatty Acids supplementation (4 g daily) significantly reduced the increase in serum IL-18 levels compared to placebo, but had no effect on IL-12 or hsCRP. The study suggests a specific anti-inflammatory effect on IL-18 pathways.", "population_specificity": "Nondiabetic patients with Stage 3-4 chronic kidney disease (n=73).", "effective_dosage": "4 g daily", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:28.359223+00:00"}
{"study_id": 201285, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the controversial role of dietary omega-3 fatty acids and esters in reducing cardiovascular risk.", "results_summary": "The study found that the role of omega-3 fatty acids in reducing cardiovascular risk remains controversial, with no clear consensus on their efficacy. The abstract does not provide specific results supporting or refuting their benefits.", "population_specificity": "Patients with cardiovascular disease or high cardiovascular risk, including those with hypercholesterolemia, hypertriglyceridemia, or combined hyperlipidemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:28.915748+00:00"}
{"study_id": 201288, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy of \u03c9-3 fatty acids in treating psoriasis by analyzing pooled data from multiple studies.", "results_summary": "The meta-analysis found significant reductions in PASI score, erythema, and scaling with \u03c9-3 supplementation, particularly at higher dosages. Improvements in itching and scaling were also noted, supporting its use for psoriasis management.", "population_specificity": "Patients with psoriasis (560 participants across 10 studies).", "effective_dosage": "Higher dosages showed more significant effects (specific amounts not detailed).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:29.044655+00:00"}
{"study_id": 201289, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if omega-3 supplementation combined with lifestyle intervention (LI) could improve metabolic and endothelial abnormalities in obese adolescents with hypertriglyceridemia.", "results_summary": "Omega-3 supplementation with LI significantly reduced triglycerides, HOMA, leptin, RBP4, ADMA, and sE levels compared to LI alone, indicating improved dyslipidemia, insulin resistance, adipokine abnormalities, and endothelial dysfunction. The combined approach was more effective than LI alone in controlling metabolic abnormalities and reducing cardiovascular risks.", "population_specificity": "Obese adolescents with hypertriglyceridemia (70 participants) compared to normal-weight adolescents (69 controls).", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:32.222548+00:00"}
{"study_id": 201290, "supplement_id": 1396, "safety_score": "75", "efficacy_score": 40, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the efficacy and safety of omega-3 fatty acid supplementation versus placebo or no treatment for maintaining vascular access patency in end-stage kidney disease patients undergoing hemodialysis.", "results_summary": "Omega-3 fatty acids showed little to no difference in preventing patency loss in arteriovenous fistulas (moderate certainty) and uncertain effects in arteriovenous grafts (very low certainty). Safety outcomes indicated minimal risk of serious adverse events but a possible increase in mild gastrointestinal reactions.", "population_specificity": "End-stage kidney disease patients undergoing hemodialysis with arteriovenous fistulas or grafts.", "effective_dosage": "Not specified in the abstract.", "study_duration": "6 to 12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:33.860167+00:00"}
{"study_id": 201293, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to provide a comprehensive review of omega-3 fatty acids, including their chemical structure, bioavailability, sources, and methods of supplementation, as well as their roles in biological functions.", "results_summary": "The study highlights the diverse roles of omega-3 fatty acids in organisms, including their presence in the central nervous system, immunomodulating properties, and susceptibility to oxidation. It also discusses effective supplementation methods and food sources.", "population_specificity": "Not specified (broad review of existing knowledge)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:35.043658+00:00"}
{"study_id": 201292, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers were attempting to determine whether supplementation with vitamin D reduces the risk of cancer or cardiovascular disease.", "results_summary": "The study found that vitamin D supplementation did not result in a lower incidence of invasive cancer or cardiovascular events compared to placebo. No significant differences were observed in secondary endpoints, including various cancer types and cardiovascular outcomes.", "population_specificity": "25,871 participants, including 5,106 black individuals.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Median follow-up of 5.3 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:35.425618+00:00"}
{"study_id": 201294, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to assess the impact of omega-3 fatty acid supplementation on mental health and quality of life in children with behavioral disorders.", "results_summary": "The study found that overall health status and quality of life significantly improved after three months, with subanalyses comparing children who received omega-3 supplementation versus those who did not.", "population_specificity": "6- to 12-year-old children with behavior-related problems (69.1% male, mean age 8.5 years).", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:36.447699+00:00"}
{"study_id": 201291, "supplement_id": 1396, "safety_score": "90", "efficacy_score": 40, "quality_score": 85, "study_goal": "The researchers aimed to determine whether supplementation with n-3 (omega-3) fatty acids reduces the incidence of major cardiovascular events or cancer in a general population at usual risk.", "results_summary": "The study found no significant reduction in major cardiovascular events or cancer incidence with n-3 supplementation compared to placebo. However, there was a modest reduction in total myocardial infarction (hazard ratio 0.72), but no significant effects on stroke, cardiovascular death, or cancer death.", "population_specificity": "25,871 participants, including 5,106 black individuals, from a general population at usual risk for cardiovascular disease and cancer.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Median follow-up of 5.3 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:36.533702+00:00"}
{"study_id": 201298, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether omega-3 fatty acid supplementation could increase physical activity levels and affect relative body weight in children aged 8-9 years.", "results_summary": "The study found no significant effects of omega-3 fatty acids on physical activity or relative body weight. Inactive children showed a slight increase in physical activity compared to active children at baseline, but overall effects were not statistically significant.", "population_specificity": "8-9-year-old children (n=362, omega-3 group n=177, placebo group n=185).", "effective_dosage": "Not specified in the abstract.", "study_duration": "15 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:38.023932+00:00"}
{"study_id": 201299, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether preoperative nutritional supplementation with Omega-3 Fatty Acids (O3FA) enhances weight loss, reduces postoperative pain, and lowers inflammatory markers compared to a standard high-protein formula in patients undergoing laparoscopic Roux-en-Y gastric bypass.", "results_summary": "The study found that O3FA supplementation led to significantly greater preoperative weight loss, reduced postoperative pain, and lower C-reactive protein levels 24 hours after surgery compared to the control group, with no significant differences in complications, mortality, or readmission rates.", "population_specificity": "Patients undergoing laparoscopic Roux-en-Y gastric bypass (n=40, 20 per group).", "effective_dosage": "Not specified (formula enriched with O3FA, total intake restricted to 900 Kcal/day).", "study_duration": "10 days before surgery, maintained up to 8 hours before the procedure.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:39.660274+00:00"}
{"study_id": 201300, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of long-chain omega-3 polyunsaturated fatty acids (n-3 PUFA) supplementation in preventing cardiovascular disease (CVD) and explore reasons for conflicting conclusions in recent meta-analyses.", "results_summary": "The study found mixed evidence for n-3 PUFA supplementation in reducing CVD risk, with limitations in study design and dosage. Promising evidence supports its role in preventing cardiac death, and ongoing trials with higher dosages may clarify its efficacy.", "population_specificity": "High cardiovascular risk subjects with hypertriglyceridemia (in ongoing trials).", "effective_dosage": "Larger dosages than previous RCTs (specific amount not stated).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:41.254132+00:00"}
{"study_id": 201301, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of n-3 PUFA supplementation in reducing liver steatosis and related metabolic abnormalities in patients with severe NAFLD.", "results_summary": "The study found that 6 months of n-3 PUFA supplementation significantly improved hepatic steatosis, lipid profile, and cardiometabolic markers, including reduced oxidative stress and increased adiponectin levels.", "population_specificity": "Twenty young male participants of French Canadian origin with severe NAFLD.", "effective_dosage": "2 g of n-3 PUFA daily.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:42.044454+00:00"}
{"study_id": 201302, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether omega-3 fatty acids reduce mortality in adults with sepsis and sepsis-induced acute respiratory distress syndrome (ARDS).", "results_summary": "Omega-3 fatty acids showed a lower mortality rate overall, but the effect was not statistically significant in most subgroups. Enteral nutrition (EN) showed some benefit in reducing mortality, while parenteral nutrition (PN) did not. The n-6 to n-3 ratio correlated with reduced mortality.", "population_specificity": "Adults with sepsis and sepsis-induced ARDS.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:43.269724+00:00"}
{"study_id": 201303, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential role of Omega-3 Fatty Acids in ameliorating age-related neuromuscular dysfunction.", "results_summary": "The study suggests that Omega-3 Fatty Acids show promise in modulating neuromuscular output by counteracting age-related changes, but current evidence seldom directly assesses neuromuscular outcomes and lacks context specific to aging.", "population_specificity": "Aging individuals with neuromuscular dysfunction.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:43.607196+00:00"}
{"study_id": 201304, "supplement_id": 1396, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the therapeutic efficacy and effectiveness of omega-3 fatty acids in treating dry eye disease and identify gaps in clinical evidence.", "results_summary": "The study found that daily oral omega-3 supplementation statistically correlates with dry eye treatment in symptomatic populations, with minimal adverse events, but noted heterogeneity in clinical endpoints and limited external validity.", "population_specificity": "General symptomatic population and induced sub-populations with dry eye disease (2,973 participants across 21 trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:44.243060+00:00"}
{"study_id": 201305, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the association between maternal intake of marine omega-3 PUFAs during pregnancy and its effects on maternal risk factors and offspring cardio-metabolic health.", "results_summary": "The study found inconsistent evidence on whether maternal omega-3 PUFA supplementation prevents pregnancy complications like gestational diabetes or pre-eclampsia, with potential benefits more pronounced in high-risk populations. Discrepancies between studies may stem from differences in design, dosage, and treatment duration.", "population_specificity": "Pregnant women, particularly high-risk populations with a history of pregnancy complications or low omega-3 intake.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:45.589026+00:00"}
{"study_id": 201306, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether 1 g daily omega-3 fatty acid supplementation prevents cardiovascular disease in people with diabetes without known arterial disease.", "results_summary": "The abstract does not report results for omega-3 fatty acids, as the study was still ongoing at the time of publication, with results expected in 2018.", "population_specificity": "15,480 people with diabetes and no known arterial disease.", "effective_dosage": "1 g omega-3 fatty acids daily.", "study_duration": "Median follow-up of at least 7 years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:46.406322+00:00"}
{"study_id": 201308, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of omega-3 fatty acid supplementation in reducing aggressive and antisocial behavior, focusing on randomized controlled trials.", "results_summary": "The study found a small effect size (d \u2248 0.20) for omega-3 supplementation in reducing aggressive and antisocial behavior in children and adults, though the mechanisms remain unclear. Further research is needed to understand dose-response relationships, optimal treatment duration, and whether impulsive aggression is more responsive to omega-3.", "population_specificity": "Children and adults exhibiting aggressive or antisocial behavior.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:48.223800+00:00"}
{"study_id": 201309, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to determine whether Omega-3 fatty acid supplementation could improve cancer cachexia in patients with unresectable pancreatic and bile duct cancer.", "results_summary": "Skeletal muscle mass significantly increased at 4 and 8 weeks after Omega-3 supplementation compared to baseline (p=0.006, p=0.002, respectively). The study suggests Omega-3 fatty acids may help mitigate cancer cachexia in these patients.", "population_specificity": "Patients with unresectable pancreatic and bile duct cancer.", "effective_dosage": "Not specified (Racol\u00ae was used as an enteral nutrient).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:49.997663+00:00"}
{"study_id": 201310, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether omega-3 fatty acids, alone or in combination with vitamin D, could reduce nocturnal enuresis in children.", "results_summary": "Omega-3 supplementation (1000 mg/day) led to a 28.2% cure rate for nocturnal enuresis, which was less effective than vitamin D alone (44.4%) or the combination (45%). The combined intervention did not enhance efficacy beyond individual treatments.", "population_specificity": "7-15-year-old children with nocturnal enuresis in Iran.", "effective_dosage": "1000 mg/day of omega-3.", "study_duration": "2 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:50.954843+00:00"}
{"study_id": 201312, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to assess whether omega-3 fatty acids could improve cerebral perfusion in patients with mild cognitive impairment.", "results_summary": "The omega-3 group showed significant increases in cerebral blood flow (26.1%) and blood volume (18.5%) compared to placebo, suggesting potential benefits for perfusion in brain regions affected by mild cognitive impairment.", "population_specificity": "Patients with mild cognitive impairment (n=13, omega-3:5, placebo:8).", "effective_dosage": "Not specified", "study_duration": "26 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:51.891843+00:00"}
{"study_id": 201313, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to assess the efficacy of omega-3 fatty acids on metabolic and inflammatory indices in patients with schizophrenia taking clozapine and sodium valproate.", "results_summary": "Omega-3 supplementation improved some anthropometric indices (weight, BMI, wrist and waist circumference) compared to placebo, with only waist circumference changes remaining significant after adjustment for serum fasted TG.", "population_specificity": "Patients with schizophrenia on stable doses of clozapine (300-400mg) for 3 months.", "effective_dosage": "4gr/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:52.197098+00:00"}
{"study_id": 201311, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the clinical effectiveness of omega-3 fatty acids in treating depressive symptoms in elderly patients over 65 years old.", "results_summary": "Omega-3 fatty acids showed a large effect in reducing depressive symptoms in elderly patients with mild to moderate depression but had no significant effect on well-being mental health groups. The benefits were significant only in those with existing depressive symptoms.", "population_specificity": "Elderly subjects older than 65 years, including both well-being mental health and depressive groups.", "effective_dosage": "Mean dose of 1.3 g/d", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:53.141384+00:00"}
{"study_id": 201314, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the effects of chronic omega-3 fatty acid supplementation on inflammatory and metabolic profiles in conditions associated with sarcopenia, such as aging, insulin resistance, type 2 diabetes, and chronic renal failure.", "results_summary": "Omega-3 fatty acids showed mixed results on plasma triglycerides in the elderly and no effects in renal patients, with no changes in systemic insulin resistance. Inflammation markers decreased in obese and elderly subjects but not in insulin-resistant or renal patients, while muscle-related parameters improved in elderly and renal patients.", "population_specificity": "Elderly individuals and patients with chronic diseases (insulin resistance, type 2 diabetes, chronic renal failure).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:54.396701+00:00"}
{"study_id": 201315, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether oral supplementation of omega-3 fatty acids reduces inflammatory markers (CRP, IL-6, TNF-\u03b1) in patients with chronic kidney disease (CKD).", "results_summary": "The meta-analysis found no statistically significant reduction in serum levels of CRP, IL-6, or TNF-\u03b1 in CKD patients receiving omega-3 fatty acids compared to controls, suggesting insufficient evidence for anti-inflammatory benefits.", "population_specificity": "Patients with chronic kidney disease (CKD), including those undergoing dialysis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:54.714864+00:00"}
{"study_id": 201316, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether parenteral omega-3 fatty acid supplementation improves immune function and clinical outcomes in postoperative gastrointestinal cancer patients.", "results_summary": "The study found that omega-3 fatty acids significantly reduced infectious complications, shortened hospital stays, and improved immune markers (CD4+ levels and CD4+/CD8+ ratio) in gastrointestinal cancer patients.", "population_specificity": "Postoperative gastrointestinal cancer patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:55.300925+00:00"}
{"study_id": 201317, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to investigate the impact of omega-3 polyunsaturated fatty acids (PUFAs) on the gut microbiota in adults.", "results_summary": "The study found that omega-3 PUFA supplementation led to some common changes in the gut microbiota, particularly a decrease in certain microbial populations. However, the effects are less well-defined compared to other dietary components like prebiotic fibers.", "population_specificity": "Adults", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:57.793008+00:00"}
{"study_id": 201318, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of omega-3 fatty acids on inflammatory mediators and biochemical markers in women with systemic lupus erythematosus (SLE).", "results_summary": "Omega-3 supplementation significantly decreased CRP levels but had no impact on IL-6, IL-10, leptin, or adiponectin concentrations. There was also evidence suggesting potential effects on total and LDL-cholesterol.", "population_specificity": "49 women with SLE (ACR1982/1997 criteria) and low disease activity.", "effective_dosage": "1080mg EPA + 200mg DHA daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:57:59.596006+00:00"}
{"study_id": 201319, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to estimate the cardiovascular benefits of indiscriminate omega-3 supplementation, expressed in quality-adjusted life years (QALY), to inform personal decisions on supplement use.", "results_summary": "Omega-3 supplementation reduced cardiac death risk by 8% (unless patients were on statins) and prolonged QALY by about a month, with greater benefits for DM-2 patients and those with a history of CV events. Older individuals gained less benefit.", "population_specificity": "General population, with specific focus on older individuals, DM-2 patients, and those with a history of CV events.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Statins (reduced efficacy of omega-3 supplementation)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:01.108846+00:00"}
{"study_id": 201322, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine if omega-3 supplementation improves cognitive function in patients with Alzheimer's disease.", "results_summary": "The study found no consistent evidence supporting the effectiveness of omega-3 supplementation in improving cognitive function in Alzheimer's patients in the short and medium term. The meta-analysis included six randomized controlled trials but did not demonstrate significant benefits.", "population_specificity": "Patients with Alzheimer's disease", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:01.460857+00:00"}
{"study_id": 201320, "supplement_id": 1396, "safety_score": "85", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether high-dose Omega-3 PUFA supplementation could reduce joint symptoms and improve quality of life in postmenopausal breast cancer patients taking aromatase inhibitors.", "results_summary": "The study found that Omega-3 supplementation was well-tolerated and feasible, with no significant changes in pain severity scores. Quality of life decreased in the placebo group but remained stable in the Omega-3 group, with a trend toward improvement at 12 weeks, though no significant differences were observed at 24 weeks.", "population_specificity": "Postmenopausal breast cancer patients starting adjuvant aromatase inhibitors.", "effective_dosage": "4.3 g/day of Omega-3 PUFAs.", "study_duration": "24 weeks.", "interactions": "Administered with aromatase inhibitors, but no other interactions mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:02.070083+00:00"}
{"study_id": 201321, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine the biosynthesis, metabolism, and roles of LC-PUFAs, as well as the impact of altering dietary intake of LA and ALA, genetic variations, and gene-diet interactions.", "results_summary": "The study suggests that rapid transitions in 18C-PUFA exposure and genetic variation in the LC-PUFA biosynthetic pathway may lead to mal-adaptations in current nutritional environments, highlighting the need for individualized approaches.", "population_specificity": "Not specified (general population with genetic variation considerations)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:02.890401+00:00"}
{"study_id": 201323, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the role of maternal omega-3 fatty acid supplementation in fetal programming, pregnancy outcomes, and long-term health risks.", "results_summary": "The study suggests that optimal placental supply of omega-3 fatty acids is critical for fetal development and may reduce risks of adverse pregnancy outcomes (e.g., GDM, preeclampsia, IUGR) and later-life metabolic disorders. Supplementation during early pregnancy could improve maternal and fetal health.", "population_specificity": "Pregnant women and their fetuses.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:03.300000+00:00"}
{"study_id": 201324, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the cost-effectiveness and potential economic impact of supplementation with long-chain omega-3 fatty acids for specific health outcomes in targeted population groups.", "results_summary": "The study found that supplementation with long-chain omega-3 fatty acids may be cost-effective or deliver cost savings for healthcare providers, particularly when targeted at specific populations with good evidence of efficacy. However, the quality of analyses was variable, and some results had considerable uncertainty.", "population_specificity": "Developed countries, specific population groups (not further specified in the abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:03.553625+00:00"}
{"study_id": 201325, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of maternal omega-3 fatty acids supplementation during pregnancy and/or lactation on offspring's body composition, including weight, length, BMI, waist circumference, fat mass, and skinfold thickness.", "results_summary": "The study found that maternal omega-3 supplementation significantly increased offspring's birth weight and postnatal waist circumference but had no significant effects on birth length, postnatal weight/length, BMI, sum of skinfold thicknesses, fat mass, or body fat percentage.", "population_specificity": "Pregnant and/or lactating women and their offspring.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:06.745255+00:00"}
{"study_id": 201326, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of Omega-3 fatty acids in reducing serum triglycerides in HIV/AIDS patients with hypertriglyceridemia on antiretroviral therapy.", "results_summary": "Omega-3 supplementation significantly reduced triglyceride levels, with greater reductions observed in patients receiving over 1000 mg of EPA/DHA or those with initial triglycerides above 200 mg/dL. The meta-analysis showed consistent results with no heterogeneity in these subgroups.", "population_specificity": "HIV/AIDS patients on antiretroviral therapy with hypertriglyceridemia.", "effective_dosage": "Over 1000 mg of EPA/DHA.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:08.022906+00:00"}
{"study_id": 201327, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to review the role of omega-3 fatty acids in resolving neuroinflammation and their potential for prevention and management of Alzheimer's disease.", "results_summary": "The abstract suggests that omega-3 fatty acids, as precursors for pro-resolving mediators, may help address impaired inflammation resolution in Alzheimer's disease, based on preclinical evidence. However, clinical outcomes are not detailed.", "population_specificity": "Patients with Alzheimer's disease (AD)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:08.700039+00:00"}
{"study_id": 201328, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the scientific evidence from 2012-2016 on the effects of omega-3 LC-PUFAs on cardiovascular risk factors such as inflammation and oxidative stress.", "results_summary": "High doses of omega-3 LC-PUFAs produced a small but significant decrease in blood pressure in older and hypertensive subjects, but no benefit was observed for managing CVD or associated complications.", "population_specificity": "Healthy subjects and CVD patients.", "effective_dosage": "High doses (specific amount not mentioned).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:09.441476+00:00"}
{"study_id": 201330, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the adherence to CONSORT guidelines and common methodological issues in studies supplementing Omega-3 Fatty Acids in children and adolescents.", "results_summary": "The study found that most included studies did not follow CONSORT guidelines, with poor reporting of flow charts and recruitment details. Adherence rates averaged 85%, while drop-out rates averaged 17%.", "population_specificity": "Children and adolescents aged 2-18 years.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:10.206058+00:00"}
{"study_id": 201329, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of omega-3 PUFAs on inflammatory markers and lipid profiles in patients with chronic Chagas cardiomyopathy.", "results_summary": "Omega-3 supplementation led to greater improvements in serum triglycerides and IL-10 levels compared to placebo, but no other significant differences were observed between groups.", "population_specificity": "Patients with chronic Chagas cardiomyopathy (23 women and 19 men).", "effective_dosage": "1.8g EPA and 1.2g DHA daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:10.353256+00:00"}
{"study_id": 201331, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers sought to evaluate the effects of omega-3 fatty acids supplementation on serum lipid profile and oxidative stress markers in pediatric patients with end-stage renal disease on regular hemodialysis.", "results_summary": "Omega-3 supplementation significantly reduced total cholesterol and increased glutathione peroxidase and superoxide dismutase levels in pediatric hemodialysis patients. The study concluded that omega-3 has beneficial effects on lipid profile and oxidative stress in this population.", "population_specificity": "Pediatric patients with end-stage renal disease on regular hemodialysis for at least 6 months.", "effective_dosage": "1-g oral omega-3 capsule once daily.", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:11.861255+00:00"}
{"study_id": 201333, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of Omega-3 Fatty Acid supplementation on serum lipids and vascular inflammation markers in patients with end-stage renal disease (ESRD).", "results_summary": "Omega-3 Fatty Acid supplementation significantly reduced triglycerides (TG), LDL, and CRP levels but had no significant effect on TC, HDL, albumin, hemoglobin, homocysteine, DBP, glucose, lipoprotein(a), or ferritin in ESRD patients.", "population_specificity": "Patients with end-stage renal disease (ESRD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:12.070889+00:00"}
{"study_id": 201334, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of omega-3 fatty acids in modulating inflammation through their conversion to specialized proresolving mediators (SPMs) and their potential therapeutic benefits.", "results_summary": "Omega-3 fatty acid supplementation at recommended daily doses increased SPM production, enhancing white blood cell responses in humans and reducing inflammation in mice, suggesting improved resolution of inflammation.", "population_specificity": "Humans and mice (specific populations not detailed).", "effective_dosage": "Within the recommended daily allowance (exact dosage not specified).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:14.671175+00:00"}
{"study_id": 201336, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of omega-3 fatty acids as biomarkers in bipolar disorder and their efficacy as a treatment for bipolar disorder symptoms.", "results_summary": "The study found that low omega-3 levels correlated with clinical severity in bipolar disorder, and omega-3 supplementation showed efficacy in open-label trials for mania and depression, though results in randomized controlled trials were mixed.", "population_specificity": "Individuals with bipolar disorder.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:16.610954+00:00"}
{"study_id": 201339, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the impact of maternal omega-3 LCPUFA supplementation on oxidative stress and inflammation during pregnancy, focusing on effects on the mother and placenta.", "results_summary": "The study suggests that omega-3 LCPUFAs exhibit antioxidant and anti-inflammatory properties, potentially reducing oxidative damage and inflammation during pregnancy, with implications for maternal and placental health.", "population_specificity": "Pregnant women, particularly those at risk of pregnancy complications.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:17.607144+00:00"}
{"study_id": 201338, "supplement_id": 1396, "safety_score": "85", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of omega-3 fatty acids on insulin resistance and serum lipids in hemodialysis patients.", "results_summary": "Omega-3 supplementation significantly reduced serum triglyceride, total cholesterol, and high-density lipoprotein cholesterol levels but did not improve insulin resistance or other measured parameters like C-reactive protein, insulin, leptin, and adiponectin.", "population_specificity": "Adult patients on maintenance hemodialysis.", "effective_dosage": "1800 mg daily.", "study_duration": "4 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:17.892219+00:00"}
{"study_id": 201337, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "To investigate the effect of \u03c9-3 fatty acids on amniotic fluid volume and uterine artery blood flow in women with unexplained oligohydramnios after 4 weeks of treatment.", "results_summary": "The \u03c9-3 group showed significant improvement in amniotic fluid index (AFI) and significant decreases in uterine artery blood flow indices (systolic/diastolic ratio, resistance index, and pulsatility index) compared to placebo.", "population_specificity": "140 women with unexplained oligohydramnios at Woman's Health Hospital, Assiut University, Egypt.", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:18.019142+00:00"}
{"study_id": 201340, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to determine the effects of omega-3 fatty acid supplementation on lipid profiles, glucose levels, and blood pressure in overweight schoolchildren with metabolic syndrome.", "results_summary": "Daily supplementation with 2.4 g of omega-3 fatty acids for 1 month improved lipid profiles, reduced fasting glucose levels, and lowered blood pressure in overweight schoolchildren with metabolic syndrome.", "population_specificity": "Overweight schoolchildren (19 girls, 20 boys) with metabolic syndrome.", "effective_dosage": "2.4 g daily", "study_duration": "1 month", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:19.840149+00:00"}
{"study_id": 201341, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the long-term cognitive, behavioral, and attention benefits of prenatal DHA supplementation in offspring at age 5 years.", "results_summary": "The study found no significant group differences in general cognitive abilities or behavioral outcomes, but offspring in the DHA group showed improved sustained attention scores compared to the placebo group. The positive effect of the home environment on cognitive abilities was attenuated in the DHA group.", "population_specificity": "Pregnant Mexican women and their offspring.", "effective_dosage": "400 mg of DHA or placebo daily.", "study_duration": "From 18-22 weeks of pregnancy until delivery.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:21.107976+00:00"}
{"study_id": 201342, "supplement_id": 1396, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the antidiabetic potential of omega-3 PUFA, its benefits, and mode of action in managing diabetes and its complications.", "results_summary": "The study suggests that omega-3 PUFA supplementation improves macro- and microvascular complications in diabetes, with potential hypoglycemic and hypolipidemic effects.", "population_specificity": "Human and animal studies (not specified further).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:58:22.510533+00:00"}
